<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="ppub">1935-2727</issn><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5501693</article-id><article-id pub-id-type="pmid">28651007</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0005707</article-id><article-id pub-id-type="publisher-id">PNTD-D-17-00109</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Tropical Diseases</subject><subj-group><subject>Neglected Tropical Diseases</subject><subj-group><subject>Chikungunya Infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Chikungunya Infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Togaviruses</subject><subj-group><subject>Alphaviruses</subject><subj-group><subject>Chikungunya Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Species Interactions</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Animals</subject><subj-group><subject>Invertebrates</subject><subj-group><subject>Arthropoda</subject><subj-group><subject>Insects</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Immunologic Techniques</subject><subj-group><subject>Immunoassays</subject><subj-group><subject>Enzyme-Linked Immunoassays</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Asia</subject><subj-group><subject>Yemen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Species Interactions</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Animals</subject><subj-group><subject>Invertebrates</subject><subj-group><subject>Arthropoda</subject><subj-group><subject>Insects</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Africa</subject><subj-group><subject>Sudan</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Africa</subject><subj-group><subject>Djibouti</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Urban Chikungunya in the Middle East and North Africa: A systematic
review</article-title><alt-title alt-title-type="running-head">Chikungunya in the MENA</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3156-1065</contrib-id><name><surname>Humphrey</surname><given-names>John M.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026;
editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Cleton</surname><given-names>Natalie B.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Reusken</surname><given-names>Chantal B. E. M.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Glesby</surname><given-names>Marshall J.</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Koopmans</surname><given-names>Marion P. G.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Abu-Raddad</surname><given-names>Laith J.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Division of Infectious Diseases, Department of Medicine, Weill Cornell
Medicine, New York, New York, United States of America</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Viroscience department, Erasmus University Medical Centre, Rotterdam, The
Netherlands</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>National Institute for Public Health and the Environment (RIVM),
Bilthoven, The Netherlands</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Healthcare Policy and Research, Weill Cornell Medicine,
Cornell University, New York, New York, United States of
America</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Infectious Disease Epidemiology Group, Weill Cornell Medicine in Qatar,
Cornell University, Qatar Foundation, Education City, Doha,
Qatar</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>College of Public Health, Hamad bin Khalifa University, Qatar Foundation,
Education City, Doha, Qatar</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Powers</surname><given-names>Ann M.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Centers for Disease Control and Prevention, UNITED
STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>john.m.humphrey@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>6</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2017</year></pub-date><volume>11</volume><issue>6</issue><elocation-id>e0005707</elocation-id><history><date date-type="received"><day>21</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>12</day><month>6</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 Humphrey et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Humphrey et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>,
which permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pntd.0005707.pdf"/><abstract><sec id="sec001"><title>Background</title><p>The epidemiology of <italic>Chikungunya virus</italic> (CHIKV) in the Middle
East and North Africa (MENA) is not well characterized despite increasing
recognition of its expanding infection and disease burden in recent
years.</p></sec><sec id="sec002"><title>Methodology / Principal findings</title><p>Following Cochrane Collaboration guidelines and reporting our findings
following PRISMA guidelines, we systematically reviewed records describing
the human prevalence and incidence, CHIKV prevalence/infection rates in
vectors, outbreaks, and reported cases for CHIKV across the MENA region. We
identified 29 human seroprevalence measures, one human incidence study, one
study reporting CHIKV infection rates in <italic>Aedes</italic>, and nine
outbreaks and case reports/series reported in the MENA from 1970&#x02013;2015.
Overall, anti-CHIKV antibody or reports of autochthonous transmission were
identified from 10 of 23 countries in the MENA region (Djibouti, Egypt,
Iraq, Iran, Kuwait, Pakistan, Saudi Arabia, Somalia, Sudan, and Yemen), with
seroprevalence measures among general populations (median 1.0%, range 0&#x02013;43%)
and acute febrile illness populations (median 9.8%, range 0&#x02013;30%). Sudan
reported the highest number of studies (n = 11) and the highest
seroprevalence among general populations (median 12%, range 0&#x02013;43%) and
undifferentiated acute febrile illness populations (median 18%, range
10&#x02013;23%). CHIKV outbreaks were reported from Djibouti, Pakistan, Sudan, and
Yemen.</p></sec><sec id="sec003"><title>Conclusions / Significance</title><p>Seroprevalence studies and outbreak reports suggest endemic transmission of
urban cycle CHIKV in at least the Red Sea region and Pakistan. However,
indications of seroprevalence despite a low quantity of CHIKV epidemiologic
research from the region suggests that CHIKV transmission is currently
underrecognized.</p></sec></abstract><abstract abstract-type="summary"><title>Author summary</title><p><italic>Chikungunya virus</italic> (CHIKV) is an alphavirus whose principal
vectors are the <italic>Aedes aegypti</italic> and <italic>Aedes
albopictus</italic> mosquitoes. Though long endemic to Asia and Africa,
detection of CHIKV has recently been reported throughout the Western Hemisphere,
including much of South America and the Caribbean. In the Middle East and North
Africa (MENA), the epidemiology of CHIKV remains poorly characterized despite
recent reports of outbreaks and novel transmission in the Arabian Peninsula. To
better understand existing data describing the epidemiology of urban CHIKV in
the MENA region, we conducted a systematic review of human prevalence studies
and incidence studies; CHIKV detections, prevalence, and infection rates in
<italic>Aedes</italic>; and reported CHIKV outbreaks, case series, and case
reports from the region. A total of 29 seroprevalence studies were identified
through our search, with anti-CHIKV antibodies and/or outbreaks detected in
Djibouti, Egypt, Iraq, Iran, Kuwait, Pakistan, Saudi Arabia, Somalia, Sudan, and
Yemen. Sudan reported the highest number of studies (n = 11) and the highest
seroprevalence among all studies. The epidemiology of urban CHIKV in other MENA
countries is less well characterized, suggesting underascertainment of cases and
the need for further research.</p></abstract><funding-group><funding-statement>This publication was made possible by support provided by the
Biomedical Research Program and the Biostatistics, Epidemiology, and
Biomathematics Research Core at the Weill Cornell Medical College in Qatar. JMH
received support from NIH Research Training Grant T32 AI007613. The statements
made herein are solely the responsibility of the authors. The funders had no
role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="4"/><page-count count="19"/></counts><custom-meta-group><custom-meta><meta-name>PLOS Publication Stage</meta-name><meta-value>vor-update-to-uncorrected-proof</meta-value></custom-meta><custom-meta><meta-name>Publication Update</meta-name><meta-value>2017-07-07</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting
Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting
Information files.</p></notes></front><body><sec sec-type="intro" id="sec004"><title>Introduction</title><p><italic>Chikungunya virus</italic> (CHIKV) is an alphavirus whose recognized global
distribution increasingly overlaps that of dengue and the distribution of their
shared mosquito vectors, <italic>Aedes aegypti</italic> and <italic>Aedes
albopictus</italic> [<xref rid="pntd.0005707.ref001" ref-type="bibr">1</xref>].
Clinical reports suggest that CHIKV may have been broadly distributed by the 1800s,
though its similar clinical presentation to <italic>Dengue virus</italic> (DENV)
makes its historic epidemiology uncertain [<xref rid="pntd.0005707.ref002" ref-type="bibr">2</xref>]. Since the first isolation of CHIKV in
Tanzania in 1952&#x02013;53 [<xref rid="pntd.0005707.ref003" ref-type="bibr">3</xref>],
large urban outbreaks have been detected in the Indian Ocean region and Latin
America, yielding millions of suspected infections and the novel discovery of
autochthonous CHIKV transmission in Mediterranean Europe in 2007 [<xref rid="pntd.0005707.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pntd.0005707.ref009" ref-type="bibr">9</xref>]. The past decade has witnessed novel reports
of CHIKV outbreaks in the Middle East and North Africa (MENA) as well. However, the
present and historic epidemiology of CHIKV in this region remains poorly
characterized.</p><p>Over the years, limited surveillance and diagnostic capacity have likely hindered the
recognition of CHIKV in the MENA region. Although the earliest possible clinical
description of CHIKV infection known to exist was first recorded in Cairo, Egypt in
1658 [<xref rid="pntd.0005707.ref002" ref-type="bibr">2</xref>], it was not until
2011 that the presence of CHIKV was first confirmed (i.e. by viral culture or
molecular detection) in the MENA during an outbreak in Yemen with over 15,000
suspected cases [<xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>]. The
CHIKV lineage responsible for this epidemic was related to the enzoonotic
East-Central-South African (ECSA) Indian Ocean Lineage and was isolated from
<italic>A</italic>. <italic>aegypti</italic>, a finding that suggested urban
cycle transmission [<xref rid="pntd.0005707.ref011" ref-type="bibr">11</xref>, <xref rid="pntd.0005707.ref012" ref-type="bibr">12</xref>]. To date, the existence of
a sylvatic transmission cycle has not been reported in the MENA region. Although
debilitating and prolonged polyarthralgias can be a recognizable hallmark of CHIKV
infection [<xref rid="pntd.0005707.ref001" ref-type="bibr">1</xref>], the clinical
syndrome can be difficult to distinguish from other mosquito-transmitted febrile
illnesses including dengue fever [<xref rid="pntd.0005707.ref002" ref-type="bibr">2</xref>, <xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>, <xref rid="pntd.0005707.ref013" ref-type="bibr">13</xref>], o&#x02019;nyong&#x02019;nyong fever [<xref rid="pntd.0005707.ref002" ref-type="bibr">2</xref>], yellow fever [<xref rid="pntd.0005707.ref014" ref-type="bibr">14</xref>], and malaria [<xref rid="pntd.0005707.ref014" ref-type="bibr">14</xref>]. Given the increasing
global impact of <italic>Aedes</italic>-transmitted arboviruses and the limited
knowledge of urban CHIKV in the MENA region, we performed a systematic review of the
literature to describe the published evidence pertaining to the epidemiology of
CHIKV in the MENA region.</p><sec id="sec005"><title>Objectives</title><p>The objective of this study was to characterize the epidemiology of urban CHIKV
in the MENA region through a systematic review of published human prevalence and
incidence studies, human outbreaks and reported cases, and studies reporting
CHIKV detections and prevalence/infection rates in <italic>Aedes</italic>
mosquitoes. The original literature search was conducted in December 2015 and
updated in May 2017.</p></sec></sec><sec sec-type="materials|methods" id="sec006"><title>Materials and methods</title><p>The materials and methods used for this review are similar to those of a systematic
review of DENV in the MENA region that we conducted in parallel to the current study
[<xref rid="pntd.0005707.ref015" ref-type="bibr">15</xref>].</p><sec id="sec007"><title>Eligibility criteria</title><p>The eligibility criteria for this study follows similar criteria that was used
for a review of DENV in the MENA region (<xref rid="pntd.0005707.t001" ref-type="table">Table 1</xref>) [<xref rid="pntd.0005707.ref015" ref-type="bibr">15</xref>]. In brief, reports containing primary
human seroprevalence or incidence, outbreaks and reported cases, and CHIKV
detections from <italic>Aedes</italic> mosquitoes in the MENA region published
in any year were considered eligible for the systematic review. For incidence
studies, those that reported the number of acute infections or seroconversions
over any time interval, or overall attack rate if assessed during an outbreak,
were eligible. Human CHIKV outbreaks, case series, and case reports in natives
and returned travelers from the MENA region were also sought from the articles
retrieved through the search databases using the original search criteria.
Outbreak reports were included if at least some of the reported cases were
laboratory-supported CHIKV infection; cases series and case reports were only
included if they were laboratory-supported. We considered any report of CHIKV
cases to constitute an outbreak if the author of the report qualified it as
such. As with DENV, there is currently no consensus on how to define CHIKV
outbreaks, so determining whether any number of cases represents a significant
deviation from baseline transmission is often unclear [<xref rid="pntd.0005707.ref015" ref-type="bibr">15</xref>].</p><table-wrap id="pntd.0005707.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005707.t001</object-id><label>Table 1</label><caption><title>Criteria for study inclusion or exclusion.</title></caption><alternatives><graphic id="pntd.0005707.t001g" xlink:href="pntd.0005707.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Study type</th><th align="left" rowspan="1" colspan="1">Inclusion Criteria</th><th align="left" rowspan="1" colspan="1">Exclusion Criteria</th></tr></thead><tbody><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Human
prevalence and incidence</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">publication characteristics</td><td align="left" rowspan="1" colspan="1">Full article or abstract published in any year,
language, setting, or human population in the MENA region;
any seroconversion interval for incidence studies or
population-based attack rate</td><td align="left" rowspan="1" colspan="1">editorials, letters to editors, reviews,
commentaries, qualitative studies, basic science research
studies, studies conducted in countries outside the MENA
region, studies conducted in animals</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">study
design</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Any randomized
or non-randomized design</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Non-empirical
research/modelled data</td></tr><tr><td align="left" rowspan="1" colspan="1">outcomes</td><td align="left" rowspan="1" colspan="1">CHIKV seroprevalence or prevalence of
laboratory-confirmed infection; CHIKV incidence (by any
laboratory method)</td><td align="left" rowspan="1" colspan="1">No human prevalence or incidence measure
reported</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Human
outbreaks</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Any outbreak
defined as such in the report; reports may include
laboratory-confirmed and suspected cases</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">No
laboratory-supported information that CHIKV was the
pathogen</td></tr><tr><td align="left" rowspan="1" colspan="1">Human case reports and case series</td><td align="left" rowspan="1" colspan="1">Any cases reported in MENA natives or in
returned travelers from a MENA country, confirmed by any
laboratory method</td><td align="left" rowspan="1" colspan="1">No laboratory method reported</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Virus
prevalence in vectors</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Reported CHIKV
prevalence in <italic>Ae</italic>. <italic>aegypti</italic>
or <italic>Ae</italic>. <italic>albopictus</italic> pools
(i.e. absolute number of positive pools); estimated
infection rates (minimum/maximum) by any laboratory
method</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Basic science
research studies, virus prevalence or CHIKV detections in
other mosquito species or in non-MENA country</td></tr><tr><td align="left" rowspan="1" colspan="1">Single virus isolations in vectors</td><td align="left" rowspan="1" colspan="1">Any reports of single CHIKV isolates or vRNA
detections from <italic>Ae</italic>.
<italic>aegypti</italic> or <italic>Ae</italic>.
<italic>albopictus</italic> obtained by any laboratory
method</td><td align="left" rowspan="1" colspan="1">Mosquito captured in non-MENA country</td></tr></tbody></table></alternatives></table-wrap><p>Finally, studies containing CHIKV prevalence in <italic>Aedes</italic> pools and
single CHIKV isolates or vRNA detections from <italic>Aedes</italic> were
included if they contained a measure of the estimated proportion of
CHIKV-infected <italic>Ae</italic>. <italic>aegypti</italic> or
<italic>Ae</italic>. <italic>albopictus</italic> at a given time and setting
in the MENA region. Prevalence studies in animals were noted but excluded from
the systematic review, as our study focused on urban cycle CHIKV mediated by
human-mosquito transmission. Our review covered the 23 countries included in the
MENA definitions of the WHO/EMRO, World Bank, and the Joint United Nations
Programme on HIV/AIDS (UNAIDS) for consistency with our systematic review of
DENV in the MENA region as well as our earlier regional analyses of various
infectious diseases such as HIV and other sexually transmitted infections and
<italic>Hepatitis C virus</italic> [<xref rid="pntd.0005707.ref016" ref-type="bibr">16</xref>&#x02013;<xref rid="pntd.0005707.ref019" ref-type="bibr">19</xref>].</p></sec><sec id="sec008"><title>Outcomes</title><p>For the systematic review, the primary outcomes were CHIKV human seroprevalence,
human CHIKV incidence, human case reports/case series of CHIKV infection in MENA
natives and returned travelers from the MENA region, CHIKV prevalence in
<italic>Aedes</italic>, and single virus isolates of CHIKV in
<italic>Aedes</italic> in the MENA region.</p></sec><sec id="sec009"><title>Data sources and search strategy</title><p>We conducted a systematic search for CHIKV in the MENA informed by the Cochrane
Collaboration guidelines [<xref rid="pntd.0005707.ref020" ref-type="bibr">20</xref>] and reported our findings using the Preferred Reporting Items
for Systematic Reviews and Meta-analyses (PRISMA) guidelines [<xref rid="pntd.0005707.ref021" ref-type="bibr">21</xref>]. The PRISMA checklist
is found in <xref ref-type="supplementary-material" rid="pntd.0005707.s002">S1
Table</xref> and our search criteria in <xref ref-type="supplementary-material" rid="pntd.0005707.s001">S1 Fig</xref>. We
searched PubMed (indexed since 1966 and selectively since 1865) and Embase
(indexed since 1988) using text and MeSH/Emtree terms exploded to include all
subheadings, as well as the World Health Organization (WHO) Index Medicus for
the Eastern Mediterranean Region, WHO African Index Medicus (both indexed since
1984), and ProMED-MENA (indexed since 1994) using only the search term
&#x0201c;chikungunya&#x0201d;.</p></sec><sec id="sec010"><title>Study selection</title><p>The methodology for this section also follows our previous review of DENV [<xref rid="pntd.0005707.ref015" ref-type="bibr">15</xref>]. Titles and abstracts
were imported into Endnote (Thompson Reuters, Philadelphia, PA, USA) and were
screened by one author (JH) with potential eligibility determined by consensus
with a second author (NC) when eligibility was unclear. Full texts of
potentially relevant records were retrieved and assessed for eligibility,
contacting the author of the report as necessary. Reference lists of all
potentially eligible articles and reviews were also searched. For this study,
&#x02018;report&#x02019; refers to the document (paper, abstract, or public health record)
containing an outcome measure of interest, while &#x02018;study&#x02019; refers to the outcome
measure(s) within that report. Hence, reports could contribute more than one
study, though multiple reports of the same study were counted only once.</p></sec><sec id="sec011"><title>Data extraction and synthesis</title><p>Data were extracted by one of the authors (JH). Data from reports in English were
extracted from the full texts, while reports in French (n = 1) and German (n =
1) were extracted from the English abstract and with the help of online language
software and French and German language speakers [<xref rid="pntd.0005707.ref022" ref-type="bibr">22</xref>]. There were no records in other
languages. Studies were compiled by country and organized by year. Prevalence
studies were stratified as follows: 1) <italic>general prevalence
studies</italic> assessing anti-CHIKV IgG prevalence (e.g. CHIKV exposure)
among individuals not suspected to have acute CHIKV infection, including
community members, blood donors, military, students, and hospitalized patients
and outpatients receiving care for non-febrile illnesses, and 2) <italic>acute
febrile illness studies</italic> assessing the prevalence of
laboratory-supported CHIKV infection (i.e. any positive laboratory test
suggesting CHIKV infection) in those with undifferentiated acute febrile illness
(AFI) or suspected arbovirus infection (IgG prevalence measures obtained during
the acute phase of illness in these studies are presumed to reflect an earlier
infection). These stratifications were made because of the different study aims
and pretest probabilities of having laboratory evidence of CHIKV infection in
these populations. Reports were summarized by country and year, along with the
sampling method, assay type/make, sample size, and any data pertaining to
alphavirus cross-reactions that was available.</p><p>For CHIKV outbreaks, we recorded the year, location, suspected or confirmed
vector, and number of cases as provided in each report. We recorded similar
information for case reports/series and cases in returned travelelers as
available. Finally, reports containing CHIKV prevalence, infection rates, and
single virus isolations in <italic>Ae</italic>. <italic>aegypti</italic> and
<italic>Ae</italic>. <italic>albopictus</italic>, both recognized urban
cycle CHIKV vectors, were also sought using the original search criteria. We
recorded the year, location, and methods of collection and laboratory methods,
as well as additional bioecological aspects of the vectors as available. The
geographic distribution of all included human prevalence studies, outbreak
reports, and case reports/series were mapped according to the first-level
administrative division (e.g. state, province) in which each event was recorded
(Tableau Software, Seattle, WA, USA).</p></sec><sec id="sec012"><title>Risk of bias assessment</title><p>The risk of bias (ROB) was assessed for each seroprevalence study based on the
Cochrane approach [<xref rid="pntd.0005707.ref020" ref-type="bibr">20</xref>]
and by evaluating the precision of the reported measures according to previously
developed methodology [<xref rid="pntd.0005707.ref023" ref-type="bibr">23</xref>, <xref rid="pntd.0005707.ref024" ref-type="bibr">24</xref>]. Each
CHIKV seroprevalence measure was considered to have a low, high, or unclear ROB
in two domains: sampling methodology and response rate. The latter was defined
as the number of tested individuals divided by the number of persons invited to
participate in the study [<xref rid="pntd.0005707.ref025" ref-type="bibr">25</xref>]. ROB was considered low if (1) sampling was probability-based
(using some form of random selection), and (2) response rate was &#x02265;80%. Studies
with missing information for either of the domains were classified as having
unclear ROB for that specific domain. We did not assess the ROB for the sampling
methodology of populations with acute febrile illness, as these are defined
populations presenting to a health facility with acute infection and no
population-based sampling is needed to capture these populations. We also did
not include the laboratory assay characteristics in our risk of bias assessment
given that the epidemiology of antigenically similar alphaviruses (e.g.
<italic>O&#x02019;nyong-nyong virus</italic> [ONNV], <italic>Sindbis virus</italic>
[SINV], and <italic>Semliki Forest virus</italic> [SFV]) in the MENA was also
unclear, and nearly all identified studies utilized in-house assays. Studies
were considered to have high precision if the number of individuals tested was &#x02265;
100. We considered this to be a reasonably sensitive cutoff for precision given
the heterogeneous epidemiology of CHIKV across the region (e.g. a prevalence of
1% has a 95% CI of 0&#x02013;3%).</p></sec></sec><sec sec-type="results" id="sec013"><title>Results</title><sec id="sec014"><title>Search results</title><p>The selection process based on PRISMA guidelines is illustrated in <xref ref-type="fig" rid="pntd.0005707.g001">Fig 1</xref> [<xref rid="pntd.0005707.ref021" ref-type="bibr">21</xref>]. Briefly, the search yielded 262
reports, 35 of which were eligible for inclusion in the study following
screening process and after the addition of 8 reports identified from reference
lists and reviews. One animal seroprevalence study was excluded, in which
anti-CHIKV antibody prevalence of 2.5% was reported in a sample of 157 rodents
captured in Pakistan. In this study, all antibodies were cross-reactive with
SINV [<xref rid="pntd.0005707.ref026" ref-type="bibr">26</xref>].</p><fig id="pntd.0005707.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005707.g001</object-id><label>Fig 1</label><caption><title>PRISMA flow diagram of report selection in the systematic
search.</title></caption><graphic xlink:href="pntd.0005707.g001"/></fig></sec><sec id="sec015"><title>Characteristics of included studies</title><p>A total of 29 human seroprevalence studies for CHIKV were identified from
eligible reports, 62% of which were conducted prior to 1990 (<xref rid="pntd.0005707.t002" ref-type="table">Table 2</xref>). <xref ref-type="fig" rid="pntd.0005707.g002">Fig 2</xref> illustrates the
geographic distribution of all published CHIKV prevalence studies, outbreaks,
and reported cases in the MENA region. Overall, anti-CHIKV antibodies were
reported from 10 of 23 countries in the MENA: Djibouti, Egypt, Iran, Iraq,
Kuwait, Pakistan, Saudi Arabia, Somalia, Sudan, and Yemen. The median
seroprevalence measures among general populations was 1.0% (range 0&#x02013;43%), and
9.8% (range 0&#x02013;30%) among populations with acute febrile illness. Sudan reported
both the highest number of studies (n = 11) and the highest seroprevalence
measures overall (median 12.9%, range 0&#x02013;43%). Ninety-three percent of all
studies utilized in-house assays; 82% of all studies that were conducted after
1990 (n = 11) utilized ELISA and/or RT-PCR (or RT-qPCR); 56% (10/18) of studies
prior to 1990 utilized hemagglutinin inhibition (HI) assays. Serologic
cross-reactions with related alphaviruses (e.g. ONNV, SINV, and SFV) or
travel-acquired infections were observed or could not be excluded in some
studies from Djibouti [<xref rid="pntd.0005707.ref027" ref-type="bibr">27</xref>], Iran [<xref rid="pntd.0005707.ref028" ref-type="bibr">28</xref>],
Kuwait [<xref rid="pntd.0005707.ref029" ref-type="bibr">29</xref>, <xref rid="pntd.0005707.ref030" ref-type="bibr">30</xref>], and Pakistan [<xref rid="pntd.0005707.ref026" ref-type="bibr">26</xref>]. Viral neutralization
testing was performed in a total of five studies from Djibouti [<xref rid="pntd.0005707.ref031" ref-type="bibr">31</xref>], Iraq [<xref rid="pntd.0005707.ref032" ref-type="bibr">32</xref>, <xref rid="pntd.0005707.ref033" ref-type="bibr">33</xref>], and Sudan [<xref rid="pntd.0005707.ref032" ref-type="bibr">32</xref>&#x02013;<xref rid="pntd.0005707.ref034" ref-type="bibr">34</xref>]. Among acute febrile illness studies,
the prevalence of laboratory-supported CHIKV infection was also highest in
Sudan, with anti-CHIKV antibody prevalence by HI or ELISA ranging from 1.8% to
30%. In Yemen, 0% of 222 cases of undifferentiated AFI were positive for CHIKV
in the eastern coastal city of Al-Mukalla in June 2010 [<xref rid="pntd.0005707.ref035" ref-type="bibr">35</xref>]. Four months later, however, an
outbreak of CHIKV was detected in the western coastal governorate of
Al-Hudaydah, Yemen, and two studies demonstrated 9.8% and 28% ELISA IgM
seroprevalence among subjects with undifferentiated AFI [<xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>, <xref rid="pntd.0005707.ref036" ref-type="bibr">36</xref>].</p><fig id="pntd.0005707.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005707.g002</object-id><label>Fig 2</label><caption><title>Geographic distribution of human prevalence studies and reported
outbreaks and cases for <italic>Chikungunya virus</italic> in the Middle
East and North Africa.</title></caption><graphic xlink:href="pntd.0005707.g002"/></fig><table-wrap id="pntd.0005707.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005707.t002</object-id><label>Table 2</label><caption><title>Human prevalence studies for <italic>Chikungunya virus</italic> in
the Middle East and North Africa (n = 29).</title></caption><alternatives><graphic id="pntd.0005707.t002g" xlink:href="pntd.0005707.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Country, Ref.</th><th align="center" rowspan="1" colspan="1">Year(s)<break/>of study<xref ref-type="table-fn" rid="t002fn001">*</xref></th><th align="center" rowspan="1" colspan="1">City or Governorate</th><th align="center" rowspan="1" colspan="1">Setting; population (age range, years)</th><th align="center" rowspan="1" colspan="1">Sampling</th><th align="center" rowspan="1" colspan="1">Assay type<xref ref-type="table-fn" rid="t002fn002"><sup>&#x02020;</sup></xref></th><th align="center" rowspan="1" colspan="1">Assay make</th><th align="center" rowspan="1" colspan="1">Sample size</th><th align="center" rowspan="1" colspan="1">Prevalence</th><th align="center" colspan="2" rowspan="1">Additional testing &#x00026;
Comments</th></tr></thead><tbody><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Djibouti</bold> (n = 4)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" colspan="2" style="background-color:#D9D9D9" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Salah [<xref rid="pntd.0005707.ref027" ref-type="bibr">27</xref>]</td><td align="center" rowspan="1" colspan="1">1987</td><td align="center" rowspan="1" colspan="1">Djibouti City</td><td align="center" rowspan="1" colspan="1">Military; healthy soldiers</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">IIFT</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" colspan="2" rowspan="1">no additional testing
performed</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Randa</td><td align="center" rowspan="1" colspan="1">Rural community; general pop.</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">IIFT</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" colspan="2" rowspan="1">no additional testing
performed</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Djibouti City</td><td align="center" rowspan="1" colspan="1">Hospital; AFI patients</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">IIFT</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1"><bold>2.4%</bold></td><td align="center" colspan="2" rowspan="1">The single IIFT+ subject was a
native of Ethiopia and was cross-reactive with SINV</td></tr><tr><td align="left" rowspan="1" colspan="1">Andayi [<xref rid="pntd.0005707.ref031" ref-type="bibr">31</xref>]</td><td align="center" rowspan="1" colspan="1">2010&#x02013;11</td><td align="center" rowspan="1" colspan="1">Djibouti City</td><td align="center" rowspan="1" colspan="1">Household survey; general
pop.(&#x0003c;1&#x02013;100)</td><td align="center" rowspan="1" colspan="1">SRS</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">914</td><td align="center" rowspan="1" colspan="1"><bold>2.6%</bold></td><td align="center" colspan="2" rowspan="1">95.9% (23/24) ELISA+ were
VNT+</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Egypt</bold> (n = 2)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" colspan="2" style="background-color:#D9D9D9" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Darwish [<xref rid="pntd.0005707.ref041" ref-type="bibr">41</xref>]</td><td align="center" rowspan="1" colspan="1">1974<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">n/s; general pop. (&#x0003c;1&#x02013;70)</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">231</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" colspan="2" rowspan="1">0% were SFV+; 16.8% were
SINV+</td></tr><tr><td align="left" rowspan="1" colspan="1">Darwish [<xref rid="pntd.0005707.ref037" ref-type="bibr">37</xref>]</td><td align="center" rowspan="1" colspan="1">1985</td><td align="center" rowspan="1" colspan="1">Cairo</td><td align="center" rowspan="1" colspan="1">Hospital; AFI patients (&#x0003e;10)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1"><bold>5.5%</bold></td><td align="center" colspan="2" rowspan="1">0% (0/55) were convalescent +; 0%
were SINV+</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Iran</bold> (n = 2)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" colspan="2" style="background-color:#D9D9D9" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Saidi [<xref rid="pntd.0005707.ref028" ref-type="bibr">28</xref>]</td><td align="center" rowspan="1" colspan="1">1970</td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">394</td><td align="center" rowspan="1" colspan="1"><bold>22.1%</bold></td><td align="center" colspan="2" rowspan="1">no additional testing
performed</td></tr><tr><td align="left" rowspan="1" colspan="1">Saidi [<xref rid="pntd.0005707.ref042" ref-type="bibr">42</xref>]</td><td align="center" rowspan="1" colspan="1">1970&#x02013;71</td><td align="center" rowspan="1" colspan="1">Caspian region</td><td align="center" rowspan="1" colspan="1">Community; children (1&#x02013;6)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" colspan="2" rowspan="1">0% were SINV+</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Iraq</bold> (n = 1)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Barakat [<xref rid="pntd.0005707.ref043" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1">2012&#x02013;13</td><td align="center" rowspan="1" colspan="1">Nasiriyah</td><td align="center" rowspan="1" colspan="1">Community; healthy medical staff, blood
donors, students, non-AFI patients (10&#x02013;82)</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">IIFT</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">399</td><td align="center" rowspan="1" colspan="1"><bold>0.5%</bold></td><td align="center" rowspan="1" colspan="1">2 of 4 ambiguous CHIKV+ samples were VNT+; 2%
(8/399) of CHIKV+ were SINV+; 6/8 SINV+ were VNT+; all SINV+
and CHIKV+ samples were negative for SFV by VNT</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Kuwait</bold> (n = 2)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" colspan="2" style="background-color:#D9D9D9" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ibrahim [<xref rid="pntd.0005707.ref029" ref-type="bibr">29</xref>]</td><td align="center" rowspan="1" colspan="1">1966&#x02013;68</td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">Multiple; blood donors,<break/>non-AFI
patients, children (1&#x02013;60)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">627</td><td align="center" rowspan="1" colspan="1"><bold>1.4%</bold></td><td align="center" colspan="2" rowspan="1">78% (7/9) CHIKV+ samples were
cross-reactive to SINV and SFV; 4.5% (28/627) were SINV+;
2.6% (16/627) were SFV+</td></tr><tr><td align="left" rowspan="1" colspan="1">Al-Nakib [<xref rid="pntd.0005707.ref030" ref-type="bibr">30</xref>]</td><td align="center" rowspan="1" colspan="1">1979&#x02013;82</td><td align="center" rowspan="1" colspan="1">Jabriya</td><td align="center" rowspan="1" colspan="1">Hospital; non-AFI patients (0&#x02013;60+)</td><td align="center" rowspan="1" colspan="1">SRS</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">502</td><td align="center" rowspan="1" colspan="1"><bold>0.4%</bold></td><td align="center" colspan="2" rowspan="1">100% (2/2) CHIKV+ samples were
cross-reactive with SINV</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Pakistan</bold> (n = 2)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" colspan="2" style="background-color:#D9D9D9" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Darwish [<xref rid="pntd.0005707.ref026" ref-type="bibr">26</xref>]</td><td align="center" rowspan="1" colspan="1">1983<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Hospital; patients</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">CF</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1"><bold>2.3%</bold></td><td align="center" colspan="2" rowspan="1">2.3% were SINV+; possible CHIKV
cross-reaction with SINV</td></tr><tr><td align="left" rowspan="1" colspan="1">Afzal [<xref rid="pntd.0005707.ref044" ref-type="bibr">44</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Hospital; AFI patients (&#x0003c;12)</td><td align="center" rowspan="1" colspan="1">Conv</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">75</td><td align="center" rowspan="1" colspan="1"><bold>4%</bold></td><td align="center" rowspan="1" colspan="1">no additional testing performed</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Somalia</bold> (n = 1)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" colspan="2" style="background-color:#D9D9D9" rowspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Botros [<xref rid="pntd.0005707.ref038" ref-type="bibr">38</xref>]</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1987</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Hargeysa</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Refugee
camp; AFI patients</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Conv.</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">HI</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">In-house</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">28</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>0.0%</bold></td><td align="center" colspan="2" style="background-color:#FFFFFF" rowspan="1">0% (0/10) convalescent samples tested were HI+; 0% (0/28)
were HI+ for SINV</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Sudan</bold> (n = 11)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" colspan="2" style="background-color:#D9D9D9" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Salim [<xref rid="pntd.0005707.ref032" ref-type="bibr">32</xref>]<break/></td><td align="center" rowspan="1" colspan="1">1973<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">Sennar</td><td align="center" rowspan="1" colspan="1">Community and clinical setting; general pop.
and non-AFI patients (&#x0003c;1&#x02013;40+)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">VNT</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1"><bold>12.9%</bold></td><td align="center" colspan="2" rowspan="1">23% (11/48) were also VNT+ for
ONNV</td></tr><tr><td align="left" rowspan="1" colspan="1">Omer [<xref rid="pntd.0005707.ref033" ref-type="bibr">33</xref>]</td><td align="center" rowspan="1" colspan="1">1976</td><td align="center" rowspan="1" colspan="1">Gezira State</td><td align="center" rowspan="1" colspan="1">Rural community; general pop. (5&#x02013;40+)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">109</td><td align="center" rowspan="1" colspan="1"><bold>24.8%</bold></td><td align="center" colspan="2" rowspan="1">0.9% (1/109) were also HI+ to
SINV; 8.2% (9/109) were VNT+ for CHIKV</td></tr><tr><td align="left" rowspan="1" colspan="1">Woodruff [<xref rid="pntd.0005707.ref045" ref-type="bibr">45</xref>]</td><td align="center" rowspan="1" colspan="1">1986</td><td align="center" rowspan="1" colspan="1">Juba</td><td align="center" rowspan="1" colspan="1">Hospital; patients with history of fever
within past 6 months and AFI patients (1&#x02013;85)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">130</td><td align="center" rowspan="1" colspan="1"><bold>23.1%</bold></td><td align="center" colspan="2" rowspan="1">3.1% (4/130) were HI+ for SINV;
2.3% (3/130) were HI+ for SFV; no observed cross-reaction
between CHIKV and SINV or SFV; 1 observed cross-reaction
between SINV and SFV</td></tr><tr><td align="left" rowspan="1" colspan="1">McCarthy [<xref rid="pntd.0005707.ref046" ref-type="bibr">46</xref>]</td><td align="center" rowspan="1" colspan="1">1988</td><td align="center" rowspan="1" colspan="1">Khartoum</td><td align="center" rowspan="1" colspan="1">Clinical setting; non-AFI patients</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1"><bold>11%</bold></td><td align="center" colspan="2" rowspan="1">1/100 (1%) were IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Khartoum</td><td align="center" rowspan="1" colspan="1">Clinical setting; AFI patients (1&#x02013;89)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">196</td><td align="center" rowspan="1" colspan="1"><bold>10%</bold></td><td align="center" colspan="2" rowspan="1">1/200 (0.5%) were IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1">Watts [<xref rid="pntd.0005707.ref047" ref-type="bibr">47</xref>]</td><td align="center" rowspan="1" colspan="1">1989</td><td align="center" rowspan="1" colspan="1">Northern state</td><td align="center" rowspan="1" colspan="1">Clinical setting; AFI patients (11&#x02013;70)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">185</td><td align="center" rowspan="1" colspan="1"><bold>12.0%</bold></td><td align="center" colspan="2" rowspan="1">no additional testing
performed</td></tr><tr><td align="left" rowspan="1" colspan="1">Farnon [<xref rid="pntd.0005707.ref014" ref-type="bibr">14</xref>]</td><td align="center" rowspan="1" colspan="1">2005</td><td align="center" rowspan="1" colspan="1">Kortalla</td><td align="center" rowspan="1" colspan="1">Community; general pop. (0&#x02013;44+)</td><td align="center" rowspan="1" colspan="1">SSCS</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">87</td><td align="center" rowspan="1" colspan="1"><bold>43%</bold></td><td align="center" colspan="2" rowspan="1">1% (1/87) was CHIKV IgM+; 7.9%
(3/38) CHIKV+ samples were SINV+</td></tr><tr><td align="left" rowspan="1" colspan="1">Gould [<xref rid="pntd.0005707.ref048" ref-type="bibr">48</xref>]</td><td align="center" rowspan="1" colspan="1">2005</td><td align="center" rowspan="1" colspan="1">South Kordofan</td><td align="center" rowspan="1" colspan="1">Clinical setting; suspected YF patients (n =
3), severe illness (n = 8), AFI patients (n = 7), healthy (n
= 16)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1"><bold>23.5%</bold></td><td align="center" colspan="2" rowspan="1">no additional testing
performed</td></tr><tr><td align="left" rowspan="1" colspan="1">Adam [<xref rid="pntd.0005707.ref034" ref-type="bibr">34</xref>]</td><td align="center" rowspan="1" colspan="1">2012&#x02013;13</td><td align="center" rowspan="1" colspan="1">Eastern and Central Sudan</td><td align="center" rowspan="1" colspan="1">Clinical setting; AFI patients
(&#x0003c;15&#x02013;45+))</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">Euroimmun</td><td align="center" rowspan="1" colspan="1">379</td><td align="center" rowspan="1" colspan="1"><bold>1.8%</bold></td><td align="center" rowspan="1" colspan="1">All ELISA+ were also IFA+ and VNT+</td></tr><tr><td align="left" rowspan="1" colspan="1">Baudin [<xref rid="pntd.0005707.ref049" ref-type="bibr">49</xref>]</td><td align="center" rowspan="1" colspan="1">2011&#x02013;12</td><td align="center" rowspan="1" colspan="1">Port Sudan</td><td align="center" rowspan="1" colspan="1">Hospital; pregnant women with fever</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">qRT-PCR</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">130</td><td align="center" rowspan="1" colspan="1"><bold>30%</bold></td><td align="center" rowspan="1" colspan="1">8 of 39 CHIKV+ patients were also positive
for <italic>Rfit Valley Fever virus</italic> by PCR or IgM
ELISA</td></tr><tr><td align="left" rowspan="1" colspan="1">Enkhtsetseg [<xref rid="pntd.0005707.ref050" ref-type="bibr">50</xref>]</td><td align="center" rowspan="1" colspan="1">2012&#x02013;13</td><td align="center" rowspan="1" colspan="1">South Sudan</td><td align="center" rowspan="1" colspan="1">Military; military seroconversion study over
~6 month period</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">632</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1">no additional testing was performed</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Tunisia</bold> (n = 1)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" colspan="2" style="background-color:#D9D9D9" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Nabli [<xref rid="pntd.0005707.ref051" ref-type="bibr">51</xref>]</td><td align="center" rowspan="1" colspan="1">1970<xref ref-type="table-fn" rid="t002fn001">*</xref></td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">n/s; children</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" colspan="2" rowspan="1">0.2% (3/1406) were HI+ for
SINV</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Yemen</bold> (n = 3)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" colspan="2" style="background-color:#D9D9D9" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Madani [<xref rid="pntd.0005707.ref035" ref-type="bibr">35</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">Hadramout</td><td align="center" rowspan="1" colspan="1">Clinical settings; suspected viral
hemorrhagic fever (3&#x02013;75)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">RT-PCR</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">222</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" colspan="2" rowspan="1">no additional testing
performed</td></tr><tr><td align="left" rowspan="1" colspan="1">Malik [<xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>]</td><td align="center" rowspan="1" colspan="1">2010&#x02013;11</td><td align="center" rowspan="1" colspan="1">Al-Hudaydah</td><td align="center" rowspan="1" colspan="1">Clinical setting; AFI patients (0&#x02013;45+)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">136</td><td align="center" rowspan="1" colspan="1"><bold>28%</bold></td><td align="center" colspan="2" rowspan="1">40% (54/136) were RT-qPCR+; 22%
(30/136) were cell culture +</td></tr><tr><td align="left" rowspan="1" colspan="1">Rezza [<xref rid="pntd.0005707.ref036" ref-type="bibr">36</xref>]</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">Al Hudaydah</td><td align="center" rowspan="1" colspan="1">Hospitals; AFI patients with &#x02018;dengue-like&#x02019;
illness (1&#x02013;60)</td><td align="center" rowspan="1" colspan="1">Conv</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">NovaLisa</td><td align="center" rowspan="1" colspan="1">400</td><td align="center" rowspan="1" colspan="1"><bold>9.8%</bold></td><td align="center" colspan="2" rowspan="1">2.8% (11/400) were RT-qPCR+; 9.4%
(33/351 negative IgM/PCR) were IgG+</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>* Indicates year of publication when year(s) of data collection not
available in report.</p></fn><fn id="t002fn002"><p><sup><bold>&#x02020;</bold></sup> All serologic assays were IgG unless
otherwise stated.</p></fn><fn id="t002fn003"><p>Abbreviations: AFI, acute febrile illness patients; CF, complement
fixation; Conv, convenience; ELISA, enzyme-linked immunosorbent
assay; HI, hemagglutinin inhibition; IFA, indirect fluorescent
antibody, IIFT, indirect immunofluorescence test; n/s, not
specified; ONNV, <italic>O&#x02019;nyong-nyong virus</italic>; pop.,
population; PCR, polymerase chain reaction; RT-qPCR, quantitative
reverse transcription PCR; SFV, <italic>Semliki Forest
virus</italic>; SINV, <italic>Sindbis virus</italic>; SRS,
simple random sampling; SSCS, single stage cluster sampling; VNT,
viral neutralization test</p></fn><fn id="t002fn004"><p>Assay Abbreviation: <italic>NovaLisa</italic> (Dietzenbach,
Germany)</p></fn></table-wrap-foot></table-wrap><p>Convalescent sera results were reported in two AFI studies, neither of which was
positive as indicated by a four-fold rise in antibody titers [<xref rid="pntd.0005707.ref037" ref-type="bibr">37</xref>, <xref rid="pntd.0005707.ref038" ref-type="bibr">38</xref>]. One study reporting detection of CHIKV
in mosquito pools was identified in our search, in which CHIKV was detected by
RT-qPCR in 26.6% of 11 pools of 30 <italic>Ae</italic>. <italic>aegypti</italic>
mosquitoes that were collected at an Eritrean refugee camp in Al Hudaydah, Yemen
during the aforementioned CHIKV outbreak [<xref rid="pntd.0005707.ref039" ref-type="bibr">39</xref>]. In this study, mosquitoes were
collected by BG-sentinel<sup>TM</sup> traps, Knock-down pyrethroid spray, and
indoor aspirations from houses of recently reported cases, and larvae were
inspected in all possible containers per house or inhabited premises. The total
container index of the sampled sites was 53.8, Breteau index was 100, and house
index was 57. <italic>Ae</italic>. <italic>aegypti</italic> adult female minimum
and maximum infection rates were 20% and 72%, respectively. There were no
published reports of single CHIKV isolations from mosquitoes or population-based
human incidence identified in our search. However, during the 2012 CHIKV
outbreak in southern Yemen, one study reported an overall CHIKV attack rate of
7.5 per 1,000 people, ranging from 5.3 among children 0&#x02013;4 years of age to 12.2
among adults &#x02265; 45 years [<xref rid="pntd.0005707.ref040" ref-type="bibr">40</xref>].</p></sec><sec id="sec016"><title>Precision and risk of bias assessment results</title><p>The quality assessment for each prevalence study is found in <xref rid="pntd.0005707.t003" ref-type="table">Table 3</xref>. Overall, 66%
(19/29) of studies contained high precision as defined by a sample size of &#x02265;100
subjects. For the risk of bias assessment, response rates were &#x02265;80% in 14%
(4/29) of studies, &#x0003c;80% in 3% (1/29) of studies, and not reported in 83%
(24/29) of studies. Among general seroprevalence studies, some form of
probability sampling (i.e. low ROB) was reported in 31% (5/16) of studies,
non-probability sampling (e.g. high ROB) in 31% (5/16) of studies, and unclear
sampling methods in 38% (6/16) of studies.</p><table-wrap id="pntd.0005707.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005707.t003</object-id><label>Table 3</label><caption><title>Precision and risk of bias assessment for <italic>Chikungunya
virus</italic> prevalence measures in the Middle East and North
Africa.</title></caption><alternatives><graphic id="pntd.0005707.t003g" xlink:href="pntd.0005707.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Country, Ref.</th><th align="center" rowspan="1" colspan="1">Year(s) of study</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" colspan="2" rowspan="1">Risk of Bias Assessment</th><th align="center" rowspan="1" colspan="1">Precision</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Sampling<xref ref-type="table-fn" rid="t003fn001">*</xref></th><th align="center" rowspan="1" colspan="1">Response rate</th><th align="center" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Djibouti</bold></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Salah [<xref rid="pntd.0005707.ref027" ref-type="bibr">27</xref>]</td><td align="center" rowspan="1" colspan="1">1987</td><td align="center" rowspan="1" colspan="1">Healthy soldiers</td><td align="center" rowspan="1" colspan="1">High ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Low</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">General population</td><td align="center" rowspan="1" colspan="1">High ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Low</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1987</td><td align="center" rowspan="1" colspan="1">AFI patients</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Low</td></tr><tr><td align="left" rowspan="1" colspan="1">Andayi [<xref rid="pntd.0005707.ref031" ref-type="bibr">31</xref>]</td><td align="center" rowspan="1" colspan="1">2010&#x02013;11</td><td align="center" rowspan="1" colspan="1">General population</td><td align="center" rowspan="1" colspan="1">Low ROB</td><td align="center" rowspan="1" colspan="1">High ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Egypt</bold></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Darwish [<xref rid="pntd.0005707.ref041" ref-type="bibr">41</xref>]</td><td align="center" rowspan="1" colspan="1">1974</td><td align="center" rowspan="1" colspan="1">General population</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">Darwish [<xref rid="pntd.0005707.ref037" ref-type="bibr">37</xref>]</td><td align="center" rowspan="1" colspan="1">1985</td><td align="center" rowspan="1" colspan="1">AFI patients</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Low</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Iran</bold></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Saidi [<xref rid="pntd.0005707.ref028" ref-type="bibr">28</xref>]</td><td align="center" rowspan="1" colspan="1">1970</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">Saidi [<xref rid="pntd.0005707.ref042" ref-type="bibr">42</xref>]</td><td align="center" rowspan="1" colspan="1">1970&#x02013;71</td><td align="center" rowspan="1" colspan="1">Children</td><td align="center" rowspan="1" colspan="1">Low ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Iraq</bold></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Barakat [<xref rid="pntd.0005707.ref043" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1">2012&#x02013;13</td><td align="center" rowspan="1" colspan="1">General population, blood donors, non-AFI
patients</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Kuwait</bold></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ibrahim [<xref rid="pntd.0005707.ref029" ref-type="bibr">29</xref>]</td><td align="center" rowspan="1" colspan="1">1966&#x02013;68</td><td align="center" rowspan="1" colspan="1">Blood donors, non-AFI patients, children</td><td align="center" rowspan="1" colspan="1">Low ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">Al-Nakib [<xref rid="pntd.0005707.ref030" ref-type="bibr">30</xref>]</td><td align="center" rowspan="1" colspan="1">1979&#x02013;82</td><td align="center" rowspan="1" colspan="1">non-AFI patients</td><td align="center" rowspan="1" colspan="1">Low ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Pakistan</bold></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Darwish [<xref rid="pntd.0005707.ref026" ref-type="bibr">26</xref>]</td><td align="center" rowspan="1" colspan="1">1983</td><td align="center" rowspan="1" colspan="1">Hospital patients</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Low</td></tr><tr><td align="left" rowspan="1" colspan="1">Afzal [<xref rid="pntd.0005707.ref044" ref-type="bibr">44</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">AFI patients</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Low</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Somalia</bold></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Botros [<xref rid="pntd.0005707.ref038" ref-type="bibr">38</xref>]</td><td align="center" rowspan="1" colspan="1">1987</td><td align="center" rowspan="1" colspan="1">AFI patients</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Low</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Sudan</bold></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Salim [<xref rid="pntd.0005707.ref032" ref-type="bibr">32</xref>]</td><td align="center" rowspan="1" colspan="1">1973<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">General population and non-AFI patients</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Low</td></tr><tr><td align="left" rowspan="1" colspan="1">Omer [<xref rid="pntd.0005707.ref033" ref-type="bibr">33</xref>]</td><td align="center" rowspan="1" colspan="1">1976</td><td align="center" rowspan="1" colspan="1">General population</td><td align="center" rowspan="1" colspan="1">High ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">Woodruff [<xref rid="pntd.0005707.ref045" ref-type="bibr">45</xref>]</td><td align="center" rowspan="1" colspan="1">1986</td><td align="center" rowspan="1" colspan="1">AFI patients</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">McCarthy [<xref rid="pntd.0005707.ref046" ref-type="bibr">46</xref>]</td><td align="center" rowspan="1" colspan="1">1988</td><td align="center" rowspan="1" colspan="1">Non-AFI patients</td><td align="center" rowspan="1" colspan="1">High ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">AFI patients</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Low ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">Watts [<xref rid="pntd.0005707.ref047" ref-type="bibr">47</xref>]</td><td align="center" rowspan="1" colspan="1">1989</td><td align="center" rowspan="1" colspan="1">AFI patients</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">Farnon [<xref rid="pntd.0005707.ref014" ref-type="bibr">14</xref>]</td><td align="center" rowspan="1" colspan="1">2005</td><td align="center" rowspan="1" colspan="1">General population</td><td align="center" rowspan="1" colspan="1">Low ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Low</td></tr><tr><td align="left" rowspan="1" colspan="1">Gould [<xref rid="pntd.0005707.ref048" ref-type="bibr">48</xref>]</td><td align="center" rowspan="1" colspan="1">2005</td><td align="center" rowspan="1" colspan="1">AFI patients</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Low ROB</td><td align="center" rowspan="1" colspan="1">Low</td></tr><tr><td align="left" rowspan="1" colspan="1">Adam [<xref rid="pntd.0005707.ref034" ref-type="bibr">34</xref>]</td><td align="center" rowspan="1" colspan="1">2013&#x02013;13</td><td align="center" rowspan="1" colspan="1">AFI patients</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">Baudin [<xref rid="pntd.0005707.ref049" ref-type="bibr">49</xref>]</td><td align="center" rowspan="1" colspan="1">2011&#x02013;12</td><td align="center" rowspan="1" colspan="1">Pregnant women with AFI</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">Enkhtsetseg [<xref rid="pntd.0005707.ref050" ref-type="bibr">50</xref>]</td><td align="center" rowspan="1" colspan="1">2012&#x02013;13</td><td align="center" rowspan="1" colspan="1">Military</td><td align="center" rowspan="1" colspan="1">High ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Tunisia</bold></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Nabil [<xref rid="pntd.0005707.ref051" ref-type="bibr">51</xref>]</td><td align="center" rowspan="1" colspan="1">1970</td><td align="center" rowspan="1" colspan="1">Children</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Yemen</bold></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Madani [<xref rid="pntd.0005707.ref035" ref-type="bibr">35</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">Suspected viral hemorrhagic fever</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Low ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">Malik [<xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>]</td><td align="center" rowspan="1" colspan="1">2010&#x02013;11</td><td align="center" rowspan="1" colspan="1">AFI patients</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Low ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr><tr><td align="left" rowspan="1" colspan="1">Rezza [<xref rid="pntd.0005707.ref036" ref-type="bibr">36</xref>]</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">Patients with dengue-like illness</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">Unclear ROB</td><td align="center" rowspan="1" colspan="1">High</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>* Since the populations of acute febrile illness or suspected
arbovirus infection are defined as populations presenting to a
health facility with acute infection, no population-based sampling
is needed to capture these populations and they are denoted &#x02018;n/a&#x02019; in
the sampling column.</p></fn><fn id="t003fn002"><p>Abbreviation: AFI, acute febrile illness</p></fn></table-wrap-foot></table-wrap><p>A total of four CHIKV outbreaks, three case reports/series, and one report of
CHIKV in returned travelers, were identified through the search databases (<xref rid="pntd.0005707.t004" ref-type="table">Table 4</xref>) and were mapped
along with the geographic distribution of prevalence studies (<xref ref-type="fig" rid="pntd.0005707.g002">Fig 2</xref>). Outbreaks were
reported from Djibouti, Sudan, Pakistan, and Yemen. In most cases, the vector
was suspected to be <italic>Ae</italic>. <italic>aegypti</italic> given its
known occurrence in the affected countries, but was only confirmed as such in
the 2011&#x02013;2012 outbreak in Yemen [<xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>].</p><table-wrap id="pntd.0005707.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005707.t004</object-id><label>Table 4</label><caption><title>Summary of reported outbreaks, case series, case reports, and cases
in travelers for <italic>Chikungunya virus</italic> in the Middle East
and North Africa.</title></caption><alternatives><graphic id="pntd.0005707.t004g" xlink:href="pntd.0005707.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Country, Year</th><th align="center" rowspan="1" colspan="1">City or Governorate</th><th align="center" rowspan="1" colspan="1">Description</th><th align="center" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="left" colspan="4" style="background-color:#D9D9D9" rowspan="1"><bold>Djibouti</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">2011</td><td align="left" rowspan="1" colspan="1">Djibouti City</td><td align="left" rowspan="1" colspan="1">Chikungunya outbreak reported was concurrent
with 2011 outbreak in Yemen; <italic>Aedes aegypti</italic>
was the suspected vector.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pntd.0005707.ref031" ref-type="bibr">31</xref>]</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"><bold>Pakistan</bold></td><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">2016&#x02013;17</td><td align="left" rowspan="1" colspan="1">Karachi</td><td align="left" rowspan="1" colspan="1">A total of 2,267 reported cases during an
outbreak from December 2016 to May 2017. <italic>Aedes
aegypti</italic> was the suspected vector.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pntd.0005707.ref052" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" colspan="4" style="background-color:#D9D9D9" rowspan="1"><bold>Saudi Arabia</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">2011</td><td align="left" rowspan="1" colspan="1">Jeddah</td><td align="left" rowspan="1" colspan="1">First autochthonous case of chikungunya
detected by qRT-PCR in Saudi Arabia; unconfirmed
vector.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pntd.0005707.ref053" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" colspan="4" style="background-color:#D9D9D9" rowspan="1"><bold>Somalia</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">2016</td><td align="left" rowspan="1" colspan="1">Mogadishu</td><td align="left" rowspan="1" colspan="1">Two travelers returning to Italy from
Mogadishu, Somalia. For both patients, testing was positive
by CHIKV IFA IgG and IgM (Euroimmun), Anti-CHIKV IgM ELISA
(Euroimmun), and PRNT.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pntd.0005707.ref054" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">2016</td><td align="left" rowspan="1" colspan="1">Mogadishu</td><td align="left" rowspan="1" colspan="1">11 cases were confirmed by RT-PCR, representing
the first reports of human CHIKV infection by Somalia;
unconfirmed vector.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pntd.0005707.ref055" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" colspan="4" style="background-color:#D9D9D9" rowspan="1"><bold>Sudan</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">2005</td><td align="left" rowspan="1" colspan="1">South Kordofan</td><td align="left" rowspan="1" colspan="1">Concurrent chikungunya transmission detected
during yellow fever outbreak; <italic>Aedes aegypti</italic>
was the suspected vector.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pntd.0005707.ref048" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">2014</td><td align="left" rowspan="1" colspan="1">Not specified</td><td align="left" rowspan="1" colspan="1">16 cases were reportd from Sudan in 2014;
unconfirmed vector</td><td align="left" rowspan="1" colspan="1">[<xref rid="pntd.0005707.ref055" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">2015</td><td align="left" rowspan="1" colspan="1">Darfur</td><td align="left" rowspan="1" colspan="1">4 laboratory-confirmed cases were reported from
Sudan in 2015; unconfirmed vector</td><td align="left" rowspan="1" colspan="1">[<xref rid="pntd.0005707.ref056" ref-type="bibr">56</xref>]</td></tr><tr><td align="left" colspan="4" style="background-color:#D9D9D9" rowspan="1"><bold>Yemen</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">2011&#x02013;12</td><td align="left" rowspan="1" colspan="1">Al Hudaydah, Lahj</td><td align="left" rowspan="1" colspan="1">Over 15,000 suspected cases during an outbreak;
<italic>Aedes aegypti</italic> was the proven
vector.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>]</td></tr></tbody></table></alternatives></table-wrap></sec></sec><sec sec-type="conclusions" id="sec017"><title>Discussion</title><p>Our review examines the epidemiology of urban CHIKV in the MENA region by summarizing
published human prevalence and incidence studies, outbreaks, reported cases, and
reports of CHIKV detected in <italic>Aedes</italic> mosquitoes. Serologic and
outbreak evidence of CHIKV transmission has been identified in the countries
surrounding the Red Sea (Djibouti, Egypt, Saudi Arabia, Somalia, Sudan, and Yemen)
and Pakistan. This distribution overlaps the known distribution of DENV in the MENA
region [<xref rid="pntd.0005707.ref015" ref-type="bibr">15</xref>]. No outbreaks,
cases of autochthonous transmission, or human seroprevalence studies were reported
from 13 of 23 countries in the MENA region, while a single seroprevalence studies in
Tunisia [<xref rid="pntd.0005707.ref051" ref-type="bibr">51</xref>] did not identify
anti-CHIKV antibodies in the populations tested. Given increasing reports of
<italic>Ae</italic>. <italic>aegypti</italic> and <italic>Ae</italic>.
<italic>albopictus</italic> occurrence and DENV transmission in the MENA over
recent years, the possibility of unrecognized CHIKV transmission or cross-border
spread of CHIKV to these countries merits consideration.</p><p>As the bulk of epidemiologic evidence for CHIKV is serologic, the genetic diversity
of CHIKV circulating in the MENA is largely unknown. To date, the only published
CHIKV strain from the MENA comes from the 2011 Yemen outbreak [<xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>]. This virus was found to be similar to the
East-Central-South African (ECSA) Indian Ocean Lineage that was responsible for the
2004&#x02013;2006 Indian Ocean epidemic [<xref rid="pntd.0005707.ref011" ref-type="bibr">11</xref>, <xref rid="pntd.0005707.ref012" ref-type="bibr">12</xref>] and
subsequent urban outbreaks in Southeast Asia, Italy, and France [<xref rid="pntd.0005707.ref057" ref-type="bibr">57</xref>]. Still, CHIKV lineages may
be diverse within North Africa and distinct from other regions in Africa. Distinct
enzootic / epidemic ECSA lineages may be circulating in Sudan, for example, given
the repeated detection of anti-CHIKV antibodies in Sudanese populations since the
1970s [<xref rid="pntd.0005707.ref032" ref-type="bibr">32</xref>, <xref rid="pntd.0005707.ref033" ref-type="bibr">33</xref>], Sudan&#x02019;s proximity to East
Africa (where CHIKV has long been endemic), and the sylvatic habitats in Sudan&#x02019;s
Nuba Mountain region where several yellow fever outbreaks may have emerged from in
the past [<xref rid="pntd.0005707.ref014" ref-type="bibr">14</xref>, <xref rid="pntd.0005707.ref032" ref-type="bibr">32</xref>, <xref rid="pntd.0005707.ref058" ref-type="bibr">58</xref>&#x02013;<xref rid="pntd.0005707.ref060" ref-type="bibr">60</xref>]. Contiguous spread of CHIKV from India to
Pakistan is similarly plausible, as is import-related outbreaks from more remote
regions, such as from South Asia to the Arabian Peninsula or from Mediterranean
Europe to North Africa.</p><p>A variety of ecologic and social risk factors may be driving the spread of
<italic>Aedes</italic> in the MENA, which we describe in detail in our recent
publication on DENV in the MENA [<xref rid="pntd.0005707.ref015" ref-type="bibr">15</xref>]. These factors include increasing urbanization [<xref rid="pntd.0005707.ref061" ref-type="bibr">61</xref>], use of open water storage
that encourages <italic>Ae</italic>. <italic>aegypti</italic> breeding [<xref rid="pntd.0005707.ref039" ref-type="bibr">39</xref>, <xref rid="pntd.0005707.ref062" ref-type="bibr">62</xref>], armed conflict and poverty [<xref rid="pntd.0005707.ref063" ref-type="bibr">63</xref>, <xref rid="pntd.0005707.ref064" ref-type="bibr">64</xref>], and extensive inter- and intra-regional
trade and migration [<xref rid="pntd.0005707.ref012" ref-type="bibr">12</xref>,
<xref rid="pntd.0005707.ref065" ref-type="bibr">65</xref>]. The 2011 CHIKV
outbreak in Yemen illustrates several vulnerabilities to
<italic>Aedes</italic>-borne arboviruses potentially faced by the MENA [<xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>]. Heavy travel and commerce
through the port city of Al Hudaydah was thought to have led to CHIKV introduction,
possibly from North African port cities along the Red Sea coast. A CHIKV outbreak
was reported in Djibouti City [<xref rid="pntd.0005707.ref031" ref-type="bibr">31</xref>] the same year of the Yemen outbreak, and the following year,
autochthonous transmission of CHIKV was noted in Saudi Arabia [<xref rid="pntd.0005707.ref053" ref-type="bibr">53</xref>]. Similar transmission patterns have been
cited as risk for DENV infection spread in the Red Sea sub-region [<xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>, <xref rid="pntd.0005707.ref012" ref-type="bibr">12</xref>, <xref rid="pntd.0005707.ref027" ref-type="bibr">27</xref>, <xref rid="pntd.0005707.ref066" ref-type="bibr">66</xref>, <xref rid="pntd.0005707.ref067" ref-type="bibr">67</xref>]. High rainfall in Al Hudaydah months prior
to the outbreak may have also amplified the <italic>Aedes</italic> population to a
level capable of sustaining an outbreak. The outbreak was not detected until nearly
16 weeks after its suspected onset, in part attributable to a lack of surveillance
and case detection, and initial misrecognition of the disease as DENV in a known
dengue-endemic area [<xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>].
Prompter initiation of vector control measures may have forestalled the
amplification of the outbreak over the following months.</p><p>Serologic cross-reactions for alphaviruses like CHIKV are well documented and
represent an important limitation of epidemiologic studies which rely on serology in
the absence of confirmatory neutralization tests. Serologic evidence of CHIKV in the
absence of neutralization tests must be interpreted with caution, as such results
may represent cross-reactions between CHIKV and another alphavirus (e.g. SINV, ONNV,
or SFV), co-cicrulation of both viruses, cross neutralization between both viriuses,
or the presence of another antigenically-related virus that induces
cross-neutralizing antibodies to both alphaviruses [<xref rid="pntd.0005707.ref068" ref-type="bibr">68</xref>]. These alphaviruses may have similar
clinical presentations and geographic distributions in the MENA region, while the
increase in international travel, intensification of trade, and the spread of
potential vectors as a result of climate change may further drive overlapping
endemicity [<xref rid="pntd.0005707.ref069" ref-type="bibr">69</xref>]. In our
review, serologic cross-reactions were reported in 9 of 14 seroprevalence studies,
most commonly due to SINV, another Old World alphavirus identified in the MENA whose
epidemiologic impact is also poorly understood [<xref rid="pntd.0005707.ref070" ref-type="bibr">70</xref>]. Like <italic>West Nile Virus</italic>,
SINV may be broadly distributed in the MENA given its enzoonotic transmission cycle
involving migratory avian hosts and ubiquitous <italic>Culex</italic> mosquitoes
[<xref rid="pntd.0005707.ref071" ref-type="bibr">71</xref>&#x02013;<xref rid="pntd.0005707.ref073" ref-type="bibr">73</xref>]. In a study by Ibrahim et al. in Kuwait,
78% (7/9) CHIKV positive samples were cross-reactive to SINV and SFV by HI testing,
while cross-reactivity between SINV and SFV occurred in an additional 9 of 21
SINV-reactive sera [<xref rid="pntd.0005707.ref039" ref-type="bibr">39</xref>]. In a
second study from Kuwait, all CHIKV positive samples were cross-reactive to SINV
[<xref rid="pntd.0005707.ref030" ref-type="bibr">30</xref>]. This evidence does
not confirm CHIKV circulation in Kuwait. Antibodies against ONNV, another Old World
alphavirus whose distribution is likely underreported, were only sought (and
confirmed by VNT) in one study from Sudan conducted in 1973 [<xref rid="pntd.0005707.ref032" ref-type="bibr">32</xref>]. Yet although the distribution of ONNV in
the MENA region requires further research, it is unlikely that the serologic studies
reporting CHIKV are primarily detecting ONNV. A one-way antigenic cross-reactivity
has been described between CHIKV and ONNV, in which antibodies against CHIKV
neutralize ONNV but anti-ONNV antibodies do not recognize CHIKV [<xref rid="pntd.0005707.ref074" ref-type="bibr">74</xref>, <xref rid="pntd.0005707.ref075" ref-type="bibr">75</xref>]. Further assurance of the detection of
CHIKV antibodies is found in the study by Andayi et al. in Djibouti, in which a
non-inactivated viral antigen was utilized for ELISA testing (allowing for selection
of more specific anti-CHIKV antibodies) and results were confirmed by
seroneutralization [<xref rid="pntd.0005707.ref031" ref-type="bibr">31</xref>].</p><p>CHIKV may continue to spread in the MENA region as it has in other regions.
Surveillance programs and clinicians should maintain alertness for CHIKV,
particularly in dengue-endemic areas, given the overlapping clinical presentation
and geographic distribution of both pathogens. Addressing this challenge will
require multiplexed serologic and molecular diagnostics able to simultaneously
detect and discriminate between CHIKV and other pathogens with overlapping clinical
manifestations, such as DENV, malaria, ONNV, <italic>Yellow fever virus</italic>,
and <italic>Zika virus</italic> [<xref rid="pntd.0005707.ref002" ref-type="bibr">2</xref>, <xref rid="pntd.0005707.ref010" ref-type="bibr">10</xref>, <xref rid="pntd.0005707.ref013" ref-type="bibr">13</xref>, <xref rid="pntd.0005707.ref014" ref-type="bibr">14</xref>, <xref rid="pntd.0005707.ref048" ref-type="bibr">48</xref>, <xref rid="pntd.0005707.ref076" ref-type="bibr">76</xref>&#x02013;<xref rid="pntd.0005707.ref080" ref-type="bibr">80</xref>]. Such diagnostics could also circumvent the
issue of cross-reactivity and the frequent unavailability of convalescent serology.
However, molecular diagnostics are limited by the presence of viral RNA or antigen
for a limited duration during acute infection. Studies to understand the
distribution of <italic>Aedes</italic> and infection rates in <italic>Aedes</italic>
in the MENA are also important, as they can inform our understanding of transmission
dynamics which is useful for vector control strategies and predicting future
transmission risk [<xref rid="pntd.0005707.ref071" ref-type="bibr">71</xref>&#x02013;<xref rid="pntd.0005707.ref073" ref-type="bibr">73</xref>]. Our review identified only
one published study of CHIKV isolated from <italic>Aedes</italic> in the region
[<xref rid="pntd.0005707.ref039" ref-type="bibr">39</xref>], depite the
published occurrence of <italic>Ae</italic>. <italic>aegypti</italic> and
<italic>Ae</italic>. <italic>albopictus</italic> in 11 and 7 MENA countries,
respectively [<xref rid="pntd.0005707.ref015" ref-type="bibr">15</xref>].</p><p>Our study was limited by its use of select databases of peer-reviewed literature with
the possible exclusion of some grey literature which may have provided additional
data (the African Index Medicus and Index Medicus for the Eastern Mediterranean
Region databases do index grey literature). Reports from public health laboratories
in each country may also have provided additional data, though we chose to focus our
review on published literature that would be available to the broader academic
community in the region. In addition, although we did not impose any publication
year restrictions in our search, Embase and the regional databases began indexing
articles after 1980, so earlier publications may have been overlooked during our
search. PubMed began indexing articles prior to the discovery of CHIKV in 1952&#x02013;53,
however. The urban cycle focus of CHIKV epidemiology must also be underscored in our
manuscript, as we did not include seroprevalence studies in animals (i.e. sylvatic
cycle) in our review criteria. Still, only one seroprevalence study in animals was
identified in our search. It is likely that our study generally reflects the
available seroprevalence literature concerning CHIKV in the MENA, as we identified
no mention of sylvatic cycle CHIKV in the MENA over the course of our review. CHIKV
may primarily exist in a human-peridomestic mosquito cycle in the MENA, as it
existis in Asia [<xref rid="pntd.0005707.ref006" ref-type="bibr">6</xref>], though
sylvatic cycle CHIKV is known to exist elsewhere in Africa [<xref rid="pntd.0005707.ref081" ref-type="bibr">81</xref>]. Non-publication of studies with small or
zero effect size may also have biased the distribution of studies identified in our
review. The absence of confirmatory neutralization tests in many studies is an
additional limitation, along with the lack of convalescent serum tests to
demonstrate antibody titer kinetics in acute infections, both of which would reduce
the likelihood of cross-reaction. Indeed, serologic cross-reactions may have
overestimated CHIKV seroprevalence in multiple studies. Finally, given the small
number of studies and sparse distribution and content of available studies, we did
not perform a meta-analysis or explore bias in overall outcome measures through a
funnel plot or Egger test nor did we exclude studies based on the risk of bias
assessment. This resulted in the inclusion of studies of varying methodological
rigor and scientific quality.</p><sec id="sec018"><title>Conclusions</title><p>In the MENA region, published reports suggest endemic circulation of CHIKV in the
Red Sea Region and Pakistan, similar to the known geographic distribution of
DENV. Published epidemiologic studies are lacking in many sub-regions, including
some <italic>Aedes</italic> and DENV endemic areas, further suggesting
underrecognition of CHIKV in the MENA. These findings articulate the need for
further research to understand the epidemiology of CHIKV in the MENA.</p></sec></sec><sec sec-type="supplementary-material" id="sec019"><title>Supporting information</title><supplementary-material content-type="local-data" id="pntd.0005707.s001"><label>S1 Fig</label><caption><title>Data sources and search criteria used for the systematic review of
<italic>Chikungunya virus</italic> in the Middle East and North
Africa.</title><p>(PDF)</p></caption><media xlink:href="pntd.0005707.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0005707.s002"><label>S1 Table</label><caption><title>Preferred Reporting Items for systematic reviews and meta-analyses
(PRISMA) checklist.</title><p>(PDF)</p></caption><media xlink:href="pntd.0005707.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We would like to thank Mary Charlson and Carol Mancuso (Weill Cornell Graduate School
of Medical Sciences, New York, USA) for their contributions to the study planning
and organization, and Ghina Mumtaz, Karima Chaabna, and Sarwat Mahmud (Weill Cornell
Medical College in Qatar) for their assistance with the study methodology.</p></ack><ref-list><title>References</title><ref id="pntd.0005707.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Weaver</surname><given-names>SC</given-names></name>, <name><surname>Lecuit</surname><given-names>M</given-names></name>. <article-title>Chikungunya virus and the global spread of a
mosquito-borne disease</article-title>. <source>N Engl J Med</source>.
<year>2015</year>;<volume>372</volume>(<issue>13</issue>):<fpage>1231</fpage>&#x02013;<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMra1406035</pub-id>
.<?supplied-pmid 25806915?><pub-id pub-id-type="pmid">25806915</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Kuno</surname><given-names>G</given-names></name>. <article-title>A Re-Examination of the History of Etiologic Confusion
between Dengue and Chikungunya</article-title>. <source>PLoS Negl Trop
Dis</source>.
<year>2015</year>;<volume>9</volume>(<issue>11</issue>):<fpage>e0004101</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0004101</pub-id>
.<?supplied-pmid 26562299?><pub-id pub-id-type="pmid">26562299</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>MC</given-names></name>. <article-title>An epidemic of virus disease in Southern Province,
Tanganyika Territory, in 1952&#x02013;53. I. Clinical features</article-title>.
<source>Trans R Soc Trop Med Hyg</source>.
<year>1955</year>;<volume>49</volume>(<issue>1</issue>):<fpage>28</fpage>&#x02013;<lpage>32</lpage>.
.<?supplied-pmid 14373834?><pub-id pub-id-type="pmid">14373834</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref004"><label>4</label><mixed-citation publication-type="other">World Health
Organization. Chikungunya Fact Sheet. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs327/en/">http://www.who.int/mediacentre/factsheets/fs327/en/</ext-link>. Accessed 29
Jan 2016.</mixed-citation></ref><ref id="pntd.0005707.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Powers</surname><given-names>AM</given-names></name>, <name><surname>Brault</surname><given-names>AC</given-names></name>, <name><surname>Tesh</surname><given-names>RB</given-names></name>, <name><surname>Weaver</surname><given-names>SC</given-names></name>. <article-title>Re-emergence of Chikungunya and O'nyong-nyong viruses:
evidence for distinct geographical lineages and distant evolutionary
relationships</article-title>. <source>J Gen Virol</source>.
<year>2000</year>;<volume>81</volume>(<issue>Pt
2</issue>):<fpage>471</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1099/0022-1317-81-2-471</pub-id>
.<?supplied-pmid 10644846?><pub-id pub-id-type="pmid">10644846</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Weaver</surname><given-names>SC</given-names></name>, <name><surname>Reisen</surname><given-names>WK</given-names></name>. <article-title>Present and future arboviral threats</article-title>.
<source>Antiviral Res</source>.
<year>2010</year>;<volume>85</volume>(<issue>2</issue>):<fpage>328</fpage>&#x02013;<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.1016/j.antiviral.2009.10.008</pub-id>
.<?supplied-pmid 19857523?><pub-id pub-id-type="pmid">19857523</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Simmons</surname><given-names>CP</given-names></name>, <name><surname>Farrar</surname><given-names>JJ</given-names></name>, <name><surname>Nguyen</surname><given-names>v V</given-names></name>, <name><surname>Wills</surname><given-names>B</given-names></name>. <article-title>Dengue</article-title>. <source>N Engl J Med</source>.
<year>2012</year>;<volume>366</volume>(<issue>15</issue>):<fpage>1423</fpage>&#x02013;<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMra1110265</pub-id>
.<?supplied-pmid 22494122?><pub-id pub-id-type="pmid">22494122</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Lambrechts</surname><given-names>L</given-names></name>, <name><surname>Scott</surname><given-names>TW</given-names></name>, <name><surname>Gubler</surname><given-names>DJ</given-names></name>. <article-title>Consequences of the expanding global distribution of
Aedes albopictus for dengue virus transmission</article-title>. <source>PLoS
Negl Trop Dis</source>.
<year>2010</year>;<volume>4</volume>(<issue>5</issue>):<fpage>e646</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0000646</pub-id>
.<?supplied-pmid 20520794?><pub-id pub-id-type="pmid">20520794</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Staples</surname><given-names>JE</given-names></name>, <name><surname>Breiman</surname><given-names>RF</given-names></name>, <name><surname>Powers</surname><given-names>AM</given-names></name>. <article-title>Chikungunya fever: an epidemiological review of a
re-emerging infectious disease</article-title>. <source>Clin Infect
Dis</source>.
<year>2009</year>;<volume>49</volume>(<issue>6</issue>):<fpage>942</fpage>&#x02013;<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1086/605496</pub-id>
.<?supplied-pmid 19663604?><pub-id pub-id-type="pmid">19663604</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Malik</surname><given-names>MR</given-names></name>, <name><surname>Mnzava</surname><given-names>A</given-names></name>, <name><surname>Mohareb</surname><given-names>E</given-names></name>, <name><surname>Zayed</surname><given-names>A</given-names></name>, <name><surname>Al Kohlani</surname><given-names>A</given-names></name>, <name><surname>Thabet</surname><given-names>AA</given-names></name>, <etal>et al</etal>
<article-title>Chikungunya outbreak in Al-Hudaydah,
Yemen, 2011: epidemiological characterization and key lessons learned for
early detection and control</article-title>. <source>J Epidemiol Glob
Health</source>.
<year>2014</year>;<volume>4</volume>(<issue>3</issue>):<fpage>203</fpage>&#x02013;<lpage>11</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jegh.2014.01.004</pub-id>
.<?supplied-pmid 25107656?><pub-id pub-id-type="pmid">25107656</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Fahmy</surname><given-names>NT</given-names></name>, <name><surname>Klena</surname><given-names>JD</given-names></name>, <name><surname>Mohamed</surname><given-names>AS</given-names></name>, <name><surname>Zayed</surname><given-names>A</given-names></name>, <name><surname>Villinski</surname><given-names>JT</given-names></name>. <article-title>Complete Genome Sequence of Chikungunya Virus Isolated
from an Aedes aegypti Mosquito during an Outbreak in Yemen,
2011</article-title>. <source>Genome announcements</source>.
<year>2015</year>;<volume>3</volume>(<issue>4</issue>). <pub-id pub-id-type="doi">10.1128/genomeA.00789-15</pub-id>
.<?supplied-pmid 26184944?><pub-id pub-id-type="pmid">26184944</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Ciccozzi</surname><given-names>M</given-names></name>, <name><surname>Lo Presti</surname><given-names>A</given-names></name>, <name><surname>Cella</surname><given-names>E</given-names></name>, <name><surname>Giovanetti</surname><given-names>M</given-names></name>, <name><surname>Lai</surname><given-names>A</given-names></name>, <name><surname>El-Sawaf</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Phylogeny of Dengue and Chikungunya
viruses in Al Hudayda governorate, Yemen</article-title>. <source>Infect
Genet Evol</source>.
<year>2014</year>;<volume>27C</volume>:<fpage>395</fpage>&#x02013;<lpage>401</lpage>.
<pub-id pub-id-type="doi">10.1016/j.meegid.2014.08.010</pub-id>
.<?supplied-pmid 25183027?><pub-id pub-id-type="pmid">25183027</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Burt</surname><given-names>FJ</given-names></name>, <name><surname>Rolph</surname><given-names>MS</given-names></name>, <name><surname>Rulli</surname><given-names>NE</given-names></name>, <name><surname>Mahalingam</surname><given-names>S</given-names></name>, <name><surname>Heise</surname><given-names>MT</given-names></name>. <article-title>Chikungunya: a re-emerging virus</article-title>.
<source>Lancet</source>.
<year>2012</year>;<volume>379</volume>(<issue>9816</issue>):<fpage>662</fpage>&#x02013;<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.1016/S0140-6736(11)60281-X</pub-id>
.<?supplied-pmid 22100854?><pub-id pub-id-type="pmid">22100854</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Farnon</surname><given-names>EC</given-names></name>, <name><surname>Gould</surname><given-names>LH</given-names></name>, <name><surname>Griffith</surname><given-names>KS</given-names></name>, <name><surname>Osman</surname><given-names>MS</given-names></name>, <name><surname>El Kholy</surname><given-names>A</given-names></name>, <name><surname>Brair</surname><given-names>ME</given-names></name>, <etal>et al</etal>
<article-title>Household-Based Sero-Epidemiologic
Survey after a Yellow Fever Epidemic, Sudan, 2005</article-title>.
<source>American Journal of Tropical Medicine and Hygiene</source>.
<year>2010</year>;<volume>82</volume>(<issue>6</issue>):<fpage>1146</fpage>&#x02013;<lpage>52</lpage>.
<pub-id pub-id-type="doi">10.4269/ajtmh.2010.09-0105</pub-id>
.<?supplied-pmid 20519615?><pub-id pub-id-type="pmid">20519615</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Humphrey</surname><given-names>JM</given-names></name>, <name><surname>Cleton</surname><given-names>NB</given-names></name>, <name><surname>Reusken</surname><given-names>CB</given-names></name>, <name><surname>Glesby</surname><given-names>MJ</given-names></name>, <name><surname>Koopmans</surname><given-names>MP</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>. <article-title>Dengue in the Middle East and North Africa: A Systematic
Review</article-title>. <source>PLoS Negl Trop Dis</source>.
<year>2016</year>;<volume>10</volume>(<issue>12</issue>):<fpage>e0005194</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0005194</pub-id>
.<?supplied-pmid 27926925?><pub-id pub-id-type="pmid">27926925</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>, <name><surname>Hilmi</surname><given-names>N</given-names></name>, <name><surname>Mumtaz</surname><given-names>G</given-names></name>, <name><surname>Benkirane</surname><given-names>M</given-names></name>, <name><surname>Akala</surname><given-names>FA</given-names></name>, <name><surname>Riedner</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Epidemiology of HIV infection in the
Middle East and North Africa</article-title>. <source>AIDS</source>.
<year>2010</year>;<volume>24</volume>
<issue>Suppl 2</issue>:<fpage>S5</fpage>&#x02013;<lpage>23</lpage>. Epub 2010/07/17.
<pub-id pub-id-type="doi">10.1097/01.aids.0000386729.56683.33</pub-id>
.<?supplied-pmid 20610949?><pub-id pub-id-type="pmid">20610949</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref017"><label>17</label><mixed-citation publication-type="book"><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>, <name><surname>Akala</surname><given-names>FA</given-names></name>, <name><surname>Semini</surname><given-names>I</given-names></name>, <name><surname>Riedner</surname><given-names>G</given-names></name>, <name><surname>Wilson</surname><given-names>D</given-names></name>, <name><surname>Tawil</surname><given-names>O</given-names></name>. <source>Characterizing the HIV/AIDS epidemic in the Middle East and
North Africa: Time for Strategic Action. Middle East and North Africa
HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO
Publication</source>. <publisher-loc>Washington DC</publisher-loc>:
<publisher-name>The World Bank Press</publisher-name>; <year>2010</year>
Available from: <ext-link ext-link-type="uri" xlink:href="https://openknowledge.worldbank.org/bitstream/handle/10986/2457/548890PUB0EPI11C10Dislosed061312010.pdf?sequence=1&#x00026;isAllowed=y">https://openknowledge.worldbank.org/bitstream/handle/10986/2457/548890PUB0EPI11C10Dislosed061312010.pdf?sequence=1&#x00026;isAllowed=y</ext-link>.
Accessed 9 Dec 2016.</mixed-citation></ref><ref id="pntd.0005707.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Mumtaz</surname><given-names>GR</given-names></name>, <name><surname>Weiss</surname><given-names>HA</given-names></name>, <name><surname>Thomas</surname><given-names>SL</given-names></name>, <name><surname>Riome</surname><given-names>S</given-names></name>, <name><surname>Setayesh</surname><given-names>H</given-names></name>, <name><surname>Riedner</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>HIV among people who inject drugs in
the Middle East and North Africa: Systematic review and data
synthesis</article-title>. <source>PLoS medicine</source>.
<year>2014</year>;<volume>11</volume>(<issue>6</issue>):<fpage>e1001663</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1001663</pub-id>
.<?supplied-pmid 24937136?><pub-id pub-id-type="pmid">24937136</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Mumtaz</surname><given-names>G</given-names></name>, <name><surname>Hilmi</surname><given-names>N</given-names></name>, <name><surname>McFarland</surname><given-names>W</given-names></name>, <name><surname>Kaplan</surname><given-names>RL</given-names></name>, <name><surname>Akala</surname><given-names>FA</given-names></name>, <name><surname>Semini</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>Are HIV epidemics among men who have
sex with men emerging in the Middle East and North Africa?: a systematic
review and data synthesis</article-title>. <source>PLoS medicine</source>.
<year>2011</year>;<volume>8</volume>(<issue>8</issue>):<fpage>e1000444</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1000444</pub-id>
.<?supplied-pmid 21829329?><pub-id pub-id-type="pmid">21829329</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref020"><label>20</label><mixed-citation publication-type="book"><name><surname>Higgins</surname><given-names>JP</given-names></name>, <name><surname>Green</surname><given-names>S</given-names></name>. <source>Cochrane handbook for systematic reviews of
interventions</source>: <publisher-name>Wiley Online
Library</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="pntd.0005707.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Moher</surname><given-names>D</given-names></name>, <name><surname>Liberati</surname><given-names>A</given-names></name>, <name><surname>Tetzlaff</surname><given-names>J</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Group</surname><given-names>P</given-names></name>. <article-title>Preferred reporting items for systematic reviews and
meta-analyses: the PRISMA statement</article-title>. <source>PLoS
medicine</source>.
<year>2009</year>;<volume>6</volume>(<issue>7</issue>):<fpage>e1000097</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id>
.<?supplied-pmid 19621072?><pub-id pub-id-type="pmid">19621072</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref022"><label>22</label><mixed-citation publication-type="other">Google Translate
Mountain View, California, USA. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.translate.google.com/">http://www.translate.google.com/</ext-link>. Accessed 30 Sept
2015.</mixed-citation></ref><ref id="pntd.0005707.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Chemaitelly</surname><given-names>H</given-names></name>, <name><surname>Chaabna</surname><given-names>K</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>. <article-title>The Epidemiology of Hepatitis C Virus in the Fertile
Crescent: Systematic Review and Meta-Analysis</article-title>. <source>PloS
one</source>.
<year>2015</year>;<volume>10</volume>(<issue>8</issue>):<fpage>e0135281</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0135281</pub-id>
.<?supplied-pmid 26296200?><pub-id pub-id-type="pmid">26296200</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Chaabna</surname><given-names>K</given-names></name>, <name><surname>Mohamoud</surname><given-names>YA</given-names></name>, <name><surname>Chemaitelly</surname><given-names>H</given-names></name>, <name><surname>Mumtaz</surname><given-names>GR</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>. <article-title>Protocol for a systematic review and meta-analysis of
hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa
sub-region of the Middle East and North Africa</article-title>. <source>Syst
Rev</source>. <year>2014</year>;<volume>3</volume>:<fpage>146</fpage>
<pub-id pub-id-type="doi">10.1186/2046-4053-3-146</pub-id>
.<?supplied-pmid 25516265?><pub-id pub-id-type="pmid">25516265</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Galea</surname><given-names>S</given-names></name>, <name><surname>Tracy</surname><given-names>M</given-names></name>. <article-title>Participation rates in epidemiologic
studies</article-title>. <source>Ann Epidemiol</source>.
<year>2007</year>;<volume>17</volume>(<issue>9</issue>):<fpage>643</fpage>&#x02013;<lpage>53</lpage>.
<pub-id pub-id-type="doi">10.1016/j.annepidem.2007.03.013</pub-id>
.<?supplied-pmid 17553702?><pub-id pub-id-type="pmid">17553702</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Darwish</surname><given-names>MA</given-names></name>, <name><surname>Hoogstraal</surname><given-names>H</given-names></name>, <name><surname>Roberts</surname><given-names>TJ</given-names></name>, <name><surname>Ahmed</surname><given-names>IP</given-names></name>, <name><surname>Omar</surname><given-names>F</given-names></name>. <article-title>A sero-epidemiological survey for certain arboviruses
(Togaviridae) in Pakistan</article-title>. <source>Trans R Soc Trop Med
Hyg</source>.
<year>1983</year>;<volume>77</volume>(<issue>4</issue>):<fpage>442</fpage>&#x02013;<lpage>5</lpage>.
.<?supplied-pmid 6314612?><pub-id pub-id-type="pmid">6314612</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Salah</surname><given-names>S</given-names></name>, <name><surname>Fox</surname><given-names>E</given-names></name>, <name><surname>Abbatte</surname><given-names>EA</given-names></name>, <name><surname>Constantine</surname><given-names>NT</given-names></name>, <name><surname>Asselin</surname><given-names>P</given-names></name>, <name><surname>Soliman</surname><given-names>AK</given-names></name>. <article-title>A negative human serosurvey of haemorrhagic fever
viruses in Djibouti</article-title>. <source>Annales de l'Institut Pasteur
Virology</source>.
<year>1988</year>;<volume>139</volume>(<issue>4</issue>):<fpage>439</fpage>&#x02013;<lpage>42</lpage>.
.<?supplied-pmid 2905609?><pub-id pub-id-type="pmid">2905609</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Saidi</surname><given-names>S</given-names></name>. <article-title>Survey of antibodies to arboviruses in human population
of Iran</article-title>. <source>Pahlavi Medical Journal</source>.
<year>1971</year>;<volume>2</volume>(<issue>3</issue>):<fpage>485</fpage>&#x02013;<lpage>90</lpage>.
</mixed-citation></ref><ref id="pntd.0005707.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Ibrahim</surname><given-names>SH</given-names></name>, <name><surname>Darwish</surname><given-names>MA</given-names></name>, <name><surname>Wahdan</surname><given-names>MH</given-names></name>, <name><surname>el-Ghoroury</surname><given-names>AA</given-names></name>. <article-title>Serologic survey of Kuwait population for evidence of
group A arbovirus infection</article-title>. <source>J Egypt Public Health
Assoc</source>.
<year>1973</year>;<volume>48</volume>(<issue>5</issue>):<fpage>308</fpage>&#x02013;<lpage>24</lpage>.
.<?supplied-pmid 4789151?><pub-id pub-id-type="pmid">4789151</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Al-Nakib</surname><given-names>W</given-names></name>, <name><surname>Lloyd</surname><given-names>G</given-names></name>, <name><surname>El-Mekki</surname><given-names>A</given-names></name>, <name><surname>Platt</surname><given-names>G</given-names></name>, <name><surname>Beeson</surname><given-names>A</given-names></name>, <name><surname>Southee</surname><given-names>T</given-names></name>. <article-title>Preliminary report on arbovirus-antibody prevalence
among patients in Kuwait: evidence of Congo/Crimean virus
infection</article-title>. <source>Trans R Soc Trop Med Hyg</source>.
<year>1984</year>;<volume>78</volume>(<issue>4</issue>):<fpage>474</fpage>&#x02013;<lpage>6</lpage>.
.<?supplied-pmid 6435292?><pub-id pub-id-type="pmid">6435292</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Andayi</surname><given-names>F</given-names></name>, <name><surname>Charrel</surname><given-names>RN</given-names></name>, <name><surname>Kieffer</surname><given-names>A</given-names></name>, <name><surname>Richet</surname><given-names>H</given-names></name>, <name><surname>Pastorino</surname><given-names>B</given-names></name>, <name><surname>Leparc-Goffart</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>A sero-epidemiological study of
arboviral fevers in Djibouti, horn of Africa</article-title>. <source>PLoS
Negl Trop Dis</source>.
<year>2014</year>;<volume>8</volume>(<issue>12</issue>):<fpage>e3299</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0003299</pub-id>
.<?supplied-pmid 25502692?><pub-id pub-id-type="pmid">25502692</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Salim</surname><given-names>AR</given-names></name>, <name><surname>Porterfield</surname><given-names>JS</given-names></name>. <article-title>A serological survey on arbovirus antibodies in the
Sudan</article-title>. <source>Trans R Soc Trop Med Hyg</source>.
<year>1973</year>;<volume>67</volume>(<issue>2</issue>):<fpage>206</fpage>&#x02013;<lpage>10</lpage>.
<pub-id pub-id-type="doi">10.1016/0035-9203(73)90145-4</pub-id>. .<?supplied-pmid 4784057?><pub-id pub-id-type="pmid">4784057</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Omer</surname><given-names>AHS</given-names></name>, <name><surname>McLaren</surname><given-names>ML</given-names></name>, <name><surname>Johnson</surname><given-names>BK</given-names></name>. <article-title>A seroepidemiological survey in the Gezira, Sudan, with
special reference to arboviruses</article-title>. <source>J Trop Med
Hyg</source>.
<year>1981</year>;<volume>84</volume>(<issue>2</issue>):<fpage>63</fpage>&#x02013;<lpage>6</lpage>.
.<?supplied-pmid 7218404?><pub-id pub-id-type="pmid">7218404</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Adam</surname><given-names>A</given-names></name>, <name><surname>Seidahmed</surname><given-names>OM</given-names></name>, <name><surname>Weber</surname><given-names>C</given-names></name>, <name><surname>Schnierle</surname><given-names>B</given-names></name>, <name><surname>Schmidt-Chanasit</surname><given-names>J</given-names></name>, <name><surname>Reiche</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Low Seroprevalence Indicates
Vulnerability of Eastern and Central Sudan to Infection with Chikungunya
Virus</article-title>. <source>Vector Borne Zoonotic Dis</source>.
<year>2016</year>;<volume>16</volume>(<issue>4</issue>):<fpage>290</fpage>&#x02013;<lpage>1</lpage>.
<pub-id pub-id-type="doi">10.1089/vbz.2015.1897</pub-id>
.<?supplied-pmid 26974266?><pub-id pub-id-type="pmid">26974266</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Madani</surname><given-names>TA</given-names></name>, <name><surname>Abuelzein</surname><given-names>ETME</given-names></name>, <name><surname>Al-Bar</surname><given-names>HMS</given-names></name>, <name><surname>Azhar</surname><given-names>EI</given-names></name>, <name><surname>Kao</surname><given-names>M</given-names></name>, <name><surname>Alshoeb</surname><given-names>HO</given-names></name>, <etal>et al</etal>
<article-title>Outbreak of viral hemorrhagic fever
caused by dengue virus type 3 in Al-Mukalla, Yemen</article-title>.
<source>BMC Infect Dis</source>.
<year>2013</year>;<volume>13</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.1186/1471-2334-13-136</pub-id>.
.<?supplied-pmid 2013189579?></mixed-citation></ref><ref id="pntd.0005707.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Rezza</surname><given-names>G</given-names></name>, <name><surname>El-Sawaf</surname><given-names>G</given-names></name>, <name><surname>Faggioni</surname><given-names>G</given-names></name>, <name><surname>Vescio</surname><given-names>F</given-names></name>, <name><surname>Al Ameri</surname><given-names>R</given-names></name>, <name><surname>De Santis</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Co-circulation of Dengue and
Chikungunya Viruses, Al Hudaydah, Yemen, 2012</article-title>. <source>Emerg
Infect Dis</source>.
<year>2014</year>;<volume>20</volume>(<issue>8</issue>):<fpage>1351</fpage>&#x02013;<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.3201/eid2008.131615</pub-id>
<?supplied-pmid 25061762?><pub-id pub-id-type="pmid">25061762</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Darwish</surname><given-names>MA</given-names></name>, <name><surname>Feinsod</surname><given-names>FM</given-names></name>, <name><surname>Scott Mc</surname><given-names>NR</given-names></name>, <name><surname>Ksiazek</surname><given-names>TG</given-names></name>, <name><surname>Botros</surname><given-names>BAM</given-names></name>, <name><surname>Farrag</surname><given-names>IH</given-names></name>, <etal>et al</etal>
<article-title>Arboviral causes of non-specific
fever and myalgia in a fever hospital patient population in Cairo,
Egypt</article-title>. <source>Trans R Soc Trop Med Hyg</source>.
<year>1987</year>;<volume>81</volume>(<issue>6</issue>):<fpage>1001</fpage>&#x02013;<lpage>3</lpage>.
<pub-id pub-id-type="doi">10.1016/0035-9203(87)90378-6</pub-id>. .<?supplied-pmid 3332500?><pub-id pub-id-type="pmid">3332500</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Botros</surname><given-names>BAM</given-names></name>, <name><surname>Watts</surname><given-names>DM</given-names></name>, <name><surname>Soliman</surname><given-names>AK</given-names></name>, <name><surname>Salib</surname><given-names>AW</given-names></name>, <name><surname>Moussa</surname><given-names>MI</given-names></name>, <name><surname>Mursal</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Serological evidence of dengue fever
among refugees, Hargeysa, Somalia</article-title>. <source>Journal of
Medical Virology</source>.
<year>1989</year>;<volume>29</volume>(<issue>2</issue>):<fpage>79</fpage>&#x02013;<lpage>81</lpage>.
.<?supplied-pmid 2600591?><pub-id pub-id-type="pmid">2600591</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Zayed</surname><given-names>A</given-names></name>, <name><surname>Awash</surname><given-names>AA</given-names></name>, <name><surname>Esmail</surname><given-names>MA</given-names></name>, <name><surname>Al-Mohamadi</surname><given-names>HA</given-names></name>, <name><surname>Al-Salwai</surname><given-names>M</given-names></name>, <name><surname>Al-Jasari</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Detection of Chikungunya virus in
Aedes aegypti during 2011 outbreak in Al Hodayda</article-title>,
<source>Yemen. Acta Tropica</source>.
<year>2012</year>;<volume>123</volume>(<issue>1</issue>):<fpage>62</fpage>&#x02013;<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1016/j.actatropica.2012.03.004</pub-id>.
<pub-id pub-id-type="doi">10.1016/j.actatropica.2012.03.004</pub-id>
.<?supplied-pmid 22469818?><pub-id pub-id-type="pmid">22469818</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Thabet</surname><given-names>A A-ES</given-names></name>, <name><surname>Najib</surname><given-names>A</given-names></name>, <name><surname>Obadi</surname><given-names>M</given-names></name>, <name><surname>Saleh</surname><given-names>M</given-names></name>, <name><surname>Al-Kohlani</surname><given-names>A</given-names></name>, <name><surname>Al-Samei</surname><given-names>A</given-names></name>. <article-title>Epidemiologic Characterization of Chikungunya Outbreak
in Lahj Governorate, Southern Yemen</article-title>. <source>J Commun Med
Health Educ</source>.
<year>2013</year>;<volume>3</volume>(<issue>7</issue>).</mixed-citation></ref><ref id="pntd.0005707.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Darwish</surname><given-names>MA</given-names></name>, <name><surname>Imam</surname><given-names>IZ</given-names></name>, <name><surname>Omar</surname><given-names>FM</given-names></name>. <article-title>A serological study on certain Arbovirus antibodies in
Egypt</article-title>. <source>J Egypt Public Health Assoc</source>.
<year>1974</year>;<volume>49</volume>(<issue>4&#x02013;5</issue>):<fpage>295</fpage>&#x02013;<lpage>301</lpage>.
.<?supplied-pmid 4470123?><pub-id pub-id-type="pmid">4470123</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Saidi</surname><given-names>S</given-names></name>. <article-title>Viral antibodies in preschool children from the Caspian
area, Iran</article-title>. <source>Iran J Public Health</source>.
<year>1974</year>;<volume>3</volume>(<issue>2</issue>):<fpage>83</fpage>&#x02013;<lpage>91</lpage>.
.<?supplied-pmid 0975149818?></mixed-citation></ref><ref id="pntd.0005707.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Barakat</surname><given-names>AM</given-names></name>, <name><surname>Smura</surname><given-names>T</given-names></name>, <name><surname>Kuivanen</surname><given-names>S</given-names></name>, <name><surname>Huhtamo</surname><given-names>E</given-names></name>, <name><surname>Kurkela</surname><given-names>S</given-names></name>, <name><surname>Putkuri</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>The Presence and Seroprevalence of
Arthropod-Borne Viruses in Nasiriyah Governorate, Southern Iraq: A
Cross-Sectional Study</article-title>. <source>Am J Trop Med Hyg</source>.
<year>2016</year>;<volume>94</volume>(<issue>4</issue>):<fpage>794</fpage>&#x02013;<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.4269/ajtmh.15-0622</pub-id>
.<?supplied-pmid 26880770?><pub-id pub-id-type="pmid">26880770</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Afzal</surname><given-names>M NS</given-names></name>, <name><surname>Sultan</surname><given-names>M</given-names></name>, <name><surname>Hanif</surname><given-names>A</given-names></name>. <article-title>Chikungunya fever among children presenting with
nonspecific febrile illness during an epidemic of dengue fever in lahore,
Pakistan</article-title>. <source>Merit Res J Med Med Sci</source>.
<year>2015</year>;<volume>3</volume>(<issue>3</issue>):<fpage>69</fpage>&#x02013;<lpage>73</lpage>.</mixed-citation></ref><ref id="pntd.0005707.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Woodruff</surname><given-names>PWR</given-names></name>, <name><surname>Morrill</surname><given-names>JC</given-names></name>, <name><surname>Burans</surname><given-names>JP</given-names></name>, <name><surname>Hyams</surname><given-names>KC</given-names></name>, <name><surname>Woody</surname><given-names>JN</given-names></name>. <article-title>A study of viral and rickettsial exposure and causes of
fever in Juba, southern Sudan</article-title>. <source>Trans R Soc Trop Med
Hyg</source>.
<year>1988</year>;<volume>82</volume>(<issue>5</issue>):<fpage>761</fpage>&#x02013;<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1016/0035-9203(88)90229-5</pub-id>. .<?supplied-pmid 2855284?><pub-id pub-id-type="pmid">2855284</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>McCarthy</surname><given-names>MC</given-names></name>, <name><surname>Haberberger</surname><given-names>RL</given-names></name>, <name><surname>Salib</surname><given-names>AW</given-names></name>, <name><surname>Soliman</surname><given-names>BA</given-names></name>, <name><surname>El-Tigani</surname><given-names>A</given-names></name>, <name><surname>Khalid</surname><given-names>IO</given-names></name>, <etal>et al</etal>
<article-title>Evaluation of arthropod-borne
viruses and other infectious disease pathogens as the causes of febrile
illnesses in the Khartoum province of Sudan</article-title>. <source>J Med
Virol</source>.
<year>1996</year>;<volume>48</volume>(<issue>2</issue>):<fpage>141</fpage>&#x02013;<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1002/(SICI)1096-9071(199602)48:2&#x0003c;141::AID-JMV4&#x0003e;3.0.CO;2-9</pub-id>
.<?supplied-pmid 8835346?><pub-id pub-id-type="pmid">8835346</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Watts</surname><given-names>DM</given-names></name>, <name><surname>El-Tigani</surname><given-names>A</given-names></name>, <name><surname>Botros</surname><given-names>BAM</given-names></name>, <name><surname>Salib</surname><given-names>AW</given-names></name>, <name><surname>Olson</surname><given-names>JG</given-names></name>, <name><surname>McCarthy</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Arthropod-borne viral infections
associated with a fever outbreak in the Northern Province of
Sudan</article-title>. <source>J Trop Med Hyg</source>.
<year>1994</year>;<volume>97</volume>(<issue>4</issue>):<fpage>228</fpage>&#x02013;<lpage>30</lpage>.
.<?supplied-pmid 8064945?><pub-id pub-id-type="pmid">8064945</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Gould</surname><given-names>LH</given-names></name>, <name><surname>Osman</surname><given-names>MS</given-names></name>, <name><surname>Farnon</surname><given-names>EC</given-names></name>, <name><surname>Griffith</surname><given-names>KS</given-names></name>, <name><surname>Godsey</surname><given-names>MS</given-names></name>, <name><surname>Karch</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>An outbreak of yellow fever with
concurrent chikungunya virus transmission in South Kordofan, Sudan,
2005</article-title>. <source>Trans R Soc Trop med Hyg</source>.
<year>2008</year>;<volume>102</volume>(<issue>12</issue>):<fpage>1247</fpage>&#x02013;<lpage>54</lpage>.
<pub-id pub-id-type="doi">10.1016/j.trstmh.2008.04.014</pub-id>
.<?supplied-pmid 18502458?><pub-id pub-id-type="pmid">18502458</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Baudin</surname><given-names>M</given-names></name>, <name><surname>Jumaa</surname><given-names>AM</given-names></name>, <name><surname>Jomma</surname><given-names>HJ</given-names></name>, <name><surname>Karsany</surname><given-names>MS</given-names></name>, <name><surname>Bucht</surname><given-names>G</given-names></name>, <name><surname>Naslund</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Association of Rift Valley fever
virus infection with miscarriage in Sudanese women: a cross-sectional
study</article-title>. <source>Lancet Glob Health</source>.
<year>2016</year>;<volume>4</volume>(<issue>11</issue>):<fpage>e864</fpage>&#x02013;<lpage>e71</lpage>.
<pub-id pub-id-type="doi">10.1016/S2214-109X(16)30176-0</pub-id>
.<?supplied-pmid 27692776?><pub-id pub-id-type="pmid">27692776</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Enkhtsetseg</surname><given-names>A</given-names></name>, <name><surname>Davadoorj</surname><given-names>R</given-names></name>, <name><surname>Fernandez</surname><given-names>S</given-names></name>, <name><surname>Mongkolsirichaikul</surname><given-names>D</given-names></name>, <name><surname>Altantuul</surname><given-names>D</given-names></name>, <name><surname>Elbegdorj</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Seroconversion to Causes of Febrile
Illness in Mongolian Peacekeepers Deployed to South Sudan</article-title>.
<source>Am J Trop Med Hyg</source>.
<year>2016</year>;<volume>95</volume>(<issue>6</issue>):<fpage>1469</fpage>&#x02013;<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.4269/ajtmh.16-0174</pub-id>
.<?supplied-pmid 27928094?><pub-id pub-id-type="pmid">27928094</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Nabli</surname><given-names>B</given-names></name>, <name><surname>Chippaux-Hyppolite</surname><given-names>C</given-names></name>, <name><surname>Chippaux</surname><given-names>A</given-names></name>, <name><surname>Tamalet</surname><given-names>J</given-names></name>. <article-title>Serological study of arboviruses in
Tunisia</article-title>. <source>Bull World Health Organ</source>.
<year>1970</year>;<volume>42</volume>(<issue>2</issue>):<fpage>297</fpage>&#x02013;<lpage>303</lpage>.
.<?supplied-pmid 5310141?><pub-id pub-id-type="pmid">5310141</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref052"><label>52</label><mixed-citation publication-type="journal"><collab>World Health
Organization Regional Office for the Eastern Mediterranean</collab>.
<article-title>Chikungunya Outbreak in Pakistan</article-title>.
<source>Weekly Epidemiological Monitor</source>.
<year>2017</year>;<volume>10</volume>(<issue>19</issue>). Available:
<ext-link ext-link-type="uri" xlink:href="http://www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/">http://www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/</ext-link>.
Accessed 13 May 2017.</mixed-citation></ref><ref id="pntd.0005707.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Hussain</surname><given-names>R</given-names></name>, <name><surname>Alomar</surname><given-names>I</given-names></name>, <name><surname>Memish</surname><given-names>ZA</given-names></name>. <article-title>Chikungunya virus: Emergence of an arthritic arbovirus
in Jeddah, Saudi Arabia</article-title>. <source>East Mediterr Health
J</source>.
<year>2013</year>;<volume>19</volume>(<issue>5</issue>):<fpage>506</fpage>&#x02013;<lpage>8</lpage>.
.<?supplied-pmid 24617133?><pub-id pub-id-type="pmid">24617133</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Zammarchi</surname><given-names>L</given-names></name>, <name><surname>Fortuna</surname><given-names>C</given-names></name>, <name><surname>Venturi</surname><given-names>G</given-names></name>, <name><surname>Rinaldi</surname><given-names>F</given-names></name>, <name><surname>Capobianco</surname><given-names>T</given-names></name>, <name><surname>Remoli</surname><given-names>ME</given-names></name>, <etal>et al</etal>
<article-title>Recent Chikungunya Virus Infection
in 2 Travelers Returning from Mogadishu, Somalia, to Italy,
2016</article-title>. <source>Emerg Infect Dis</source>.
<year>2016</year>;<volume>22</volume>(<issue>11</issue>):<fpage>2025</fpage>&#x02013;<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.3201/eid2211.161225</pub-id>
.<?supplied-pmid 27513985?><pub-id pub-id-type="pmid">27513985</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref055"><label>55</label><mixed-citation publication-type="journal"><collab>World Health
Organization Regional Office for the Eastern Mediterranean</collab>.
<article-title>Chikungunya in Somalia</article-title>. <source>Weekly
Epidemiological Monitor</source>.
<year>2017</year>;<volume>9</volume>(<issue>24</issue>). Available:
<ext-link ext-link-type="uri" xlink:href="http://www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/">http://www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/</ext-link>.
Accessed 13 May 2017.</mixed-citation></ref><ref id="pntd.0005707.ref056"><label>56</label><mixed-citation publication-type="other">ProMED-mail. Viral
hemorrhagic fever: (Darfur) fatal, WHO, MOH. ProMED-mail. 2015. 25 Oct:
20151102.3760616. &#x0003c;<ext-link ext-link-type="uri" xlink:href="http://www.promedmail.org">http://www.promedmail.org</ext-link>&#x0003e;. Accessed 13 May
2017.</mixed-citation></ref><ref id="pntd.0005707.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>R</given-names></name>, <name><surname>Puri</surname><given-names>V</given-names></name>, <name><surname>Fedorova</surname><given-names>N</given-names></name>, <name><surname>Lin</surname><given-names>D</given-names></name>, <name><surname>Hari</surname><given-names>KL</given-names></name>, <name><surname>Jain</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Comprehensive Genome-Scale
Phylogenetic Study Provides New Insights on the Global Expansion of
Chikungunya Virus</article-title>. <source>J Virol</source>.
<year>2016</year>
<pub-id pub-id-type="doi">10.1128/JVI.01166-16</pub-id>
.<?supplied-pmid 27654297?><pub-id pub-id-type="pmid">27654297</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>RM</given-names></name>, <name><surname>Haseeb</surname><given-names>MA</given-names></name>, <name><surname>Work</surname><given-names>TH</given-names></name>. <article-title>A regional reconnaissance on yellow fever in the Sudan;
with special reference to primate hosts</article-title>. <source>Bull World
Health Organ</source>.
<year>1955</year>;<volume>12</volume>(<issue>5</issue>):<fpage>711</fpage>&#x02013;<lpage>25</lpage>.
.<?supplied-pmid 14379007?><pub-id pub-id-type="pmid">14379007</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref059"><label>59</label><mixed-citation publication-type="journal"><collab>World Health
Organization Regional Office for the Eastern Mediterranean</collab>.
<article-title>Acute haemorrhagic fever remained a public health threat in
EMR</article-title>. <source>Weekly Epidemiological Monitor</source>.
<year>2008</year>;<volume>1</volume>(<issue>49</issue>). Available:
<ext-link ext-link-type="uri" xlink:href="http://www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/">http://www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/</ext-link>.
Accessed 13 May 2017.</mixed-citation></ref><ref id="pntd.0005707.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Markoff</surname><given-names>L</given-names></name>. <article-title>Yellow fever outbreak in Sudan</article-title>.
<source>N Engl J Med</source>.
<year>2013</year>;<volume>368</volume>(<issue>8</issue>):<fpage>689</fpage>&#x02013;<lpage>91</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMp1300772</pub-id>
.<?supplied-pmid 23387798?><pub-id pub-id-type="pmid">23387798</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref061"><label>61</label><mixed-citation publication-type="other">The World Bank Group.
The Middle East and North Africa: Urban Development 2015. Available from:
<ext-link ext-link-type="uri" xlink:href="http://go.worldbank.org/Y88FI6V7R0">http://go.worldbank.org/Y88FI6V7R0</ext-link>. Accessed 8 Feb
2016.</mixed-citation></ref><ref id="pntd.0005707.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Soghaier</surname><given-names>MA</given-names></name>, <name><surname>Mahmood</surname><given-names>SF</given-names></name>, <name><surname>Pasha</surname><given-names>O</given-names></name>, <name><surname>Azam</surname><given-names>SI</given-names></name>, <name><surname>Karsani</surname><given-names>MM</given-names></name>, <name><surname>Elmangory</surname><given-names>MM</given-names></name>, <etal>et al</etal>
<article-title>Factors associated with dengue fever
IgG sero-prevalence in South Kordofan State, Sudan, in 2012: Reporting
prevalence ratios</article-title>. <source>J Infect Public Health</source>.
<year>2014</year>;<volume>7</volume>(<issue>1</issue>):<fpage>54</fpage>&#x02013;<lpage>61</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jiph.2013.07.008</pub-id>
.<?supplied-pmid 24210245?><pub-id pub-id-type="pmid">24210245</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Jaffer</surname><given-names>A</given-names></name>, <name><surname>Hotez</surname><given-names>PJ</given-names></name>. <article-title>Somalia: A Nation at the Crossroads of Extreme Poverty,
Conflict, and Neglected Tropical Diseases</article-title>. <source>PLoS Negl
Trop Dis</source>.
<year>2016</year>;<volume>10</volume>(<issue>9</issue>):<fpage>e0004670</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0004670</pub-id>
.<?supplied-pmid 27685261?><pub-id pub-id-type="pmid">27685261</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Hotez</surname><given-names>PJ</given-names></name>. <article-title>Combating the next lethal epidemic</article-title>.
<source>Science</source>.
<year>2015</year>;<volume>348</volume>(<issue>6232</issue>):<fpage>296</fpage>&#x02013;<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1126/science.348.6232.296-b</pub-id>
.<?supplied-pmid 25883348?><pub-id pub-id-type="pmid">25883348</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref065"><label>65</label><mixed-citation publication-type="other">World Health
Organization. Dengue: Guidelines for Diagnosis, Treatement, Prevention and
Control. Geneva, Switzerland. 2009. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf">http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf</ext-link>
Accessed 1 September 2016.</mixed-citation></ref><ref id="pntd.0005707.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Rodier</surname><given-names>GR</given-names></name>, <name><surname>Gubler</surname><given-names>DJ</given-names></name>, <name><surname>Cope</surname><given-names>SE</given-names></name>, <name><surname>Cropp</surname><given-names>CB</given-names></name>, <name><surname>Soliman</surname><given-names>AK</given-names></name>, <name><surname>Polycarpe</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Epidemic dengue 2 in the city of
Djibouti 1991&#x02013;1992</article-title>. <source>Trans R Soc Trop Med
Hyg</source>.
<year>1996</year>;<volume>90</volume>(<issue>3</issue>):<fpage>237</fpage>&#x02013;<lpage>40</lpage>.
<pub-id pub-id-type="doi">10.1016/S0035-9203(96)90228-X</pub-id>. .<?supplied-pmid 8758061?><pub-id pub-id-type="pmid">8758061</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Seidahmed</surname><given-names>OME</given-names></name>, <name><surname>Hassan</surname><given-names>SA</given-names></name>, <name><surname>Soghaier</surname><given-names>MA</given-names></name>, <name><surname>Siam</surname><given-names>HAM</given-names></name>, <name><surname>Ahmed</surname><given-names>FTA</given-names></name>, <name><surname>Elkarsany</surname><given-names>MM</given-names></name>, <etal>et al</etal>
<article-title>Spatial and Temporal Patterns of
Dengue Transmission along a Red Sea Coastline: A Longitudinal Entomological
and Serological Survey in Port Sudan City</article-title>. <source>PLoS Negl
Trop Dis</source>. <year>2012</year>;<volume>6</volume>(<issue>9</issue>).
<pub-id pub-id-type="doi">10.1371/journal.pntd.0001821</pub-id>. .<?supplied-pmid 2012579248?></mixed-citation></ref><ref id="pntd.0005707.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>LaBeaud</surname><given-names>AD</given-names></name>, <name><surname>Banda</surname><given-names>T</given-names></name>, <name><surname>Brichard</surname><given-names>J</given-names></name>, <name><surname>Muchiri</surname><given-names>EM</given-names></name>, <name><surname>Mungai</surname><given-names>PL</given-names></name>, <name><surname>Mutuku</surname><given-names>FM</given-names></name>, <etal>et al</etal>
<article-title>High rates of o'nyong nyong and
Chikungunya virus transmission in coastal Kenya</article-title>.
<source>PLoS Negl Trop Dis</source>.
<year>2015</year>;<volume>9</volume>(<issue>2</issue>):<fpage>e0003436</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0003436</pub-id>
.<?supplied-pmid 25658762?><pub-id pub-id-type="pmid">25658762</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Hassing</surname><given-names>RJ</given-names></name>, <name><surname>Leparc-Goffart</surname><given-names>I</given-names></name>, <name><surname>Tolou</surname><given-names>H</given-names></name>, <name><surname>van Doornum</surname><given-names>G</given-names></name>, <name><surname>van Genderen</surname><given-names>PJ</given-names></name>. <article-title>Cross-reactivity of antibodies to viruses belonging to
the Semliki forest serocomplex</article-title>. <source>Euro
surveillance</source>.
<year>2010</year>;<volume>15</volume>(<issue>23</issue>). .<?supplied-pmid 20546691?><pub-id pub-id-type="pmid">20546691</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Adouchief</surname><given-names>S</given-names></name>, <name><surname>Smura</surname><given-names>T</given-names></name>, <name><surname>Sane</surname><given-names>J</given-names></name>, <name><surname>Vapalahti</surname><given-names>O</given-names></name>, <name><surname>Kurkela</surname><given-names>S</given-names></name>. <article-title>Sindbis virus as a human pathogen-epidemiology, clinical
picture and pathogenesis</article-title>. <source>Rev Med Virol</source>.
<year>2016</year>;<volume>26</volume>(<issue>4</issue>):<fpage>221</fpage>&#x02013;<lpage>41</lpage>.
<pub-id pub-id-type="doi">10.1002/rmv.1876</pub-id>
.<?supplied-pmid 26990827?><pub-id pub-id-type="pmid">26990827</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Kraemer</surname><given-names>MU</given-names></name>, <name><surname>Sinka</surname><given-names>ME</given-names></name>, <name><surname>Duda</surname><given-names>KA</given-names></name>, <name><surname>Mylne</surname><given-names>AQ</given-names></name>, <name><surname>Shearer</surname><given-names>FM</given-names></name>, <name><surname>Barker</surname><given-names>CM</given-names></name>, <etal>et al</etal>
<article-title>The global distribution of the
arbovirus vectors Aedes aegypti and Ae. albopictus</article-title>.
<source>Elife</source>.
<year>2015</year>;<volume>4</volume>:<fpage>e08347</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.08347</pub-id>
.<?supplied-pmid 26126267?><pub-id pub-id-type="pmid">26126267</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Nsoesie</surname><given-names>EO</given-names></name>, <name><surname>Kraemer</surname><given-names>MU</given-names></name>, <name><surname>Golding</surname><given-names>N</given-names></name>, <name><surname>Pigott</surname><given-names>DM</given-names></name>, <name><surname>Brady</surname><given-names>OJ</given-names></name>, <name><surname>Moyes</surname><given-names>CL</given-names></name>, <etal>et al</etal>
<article-title>Global Distribution and
Environmental Suitability for Chikungunya Virus, 1952&#x02013;2015</article-title>.
<source>Euro Surveillance</source>.
<year>2016</year>;<volume>21</volume>(<issue>20</issue>):pii = 30234.
<pub-id pub-id-type="doi">10.2807/1560-7917</pub-id>.</mixed-citation></ref><ref id="pntd.0005707.ref073"><label>73</label><mixed-citation publication-type="book"><collab>European Centre
for Disease Prevention and Control</collab>. <source>Guidelines for the
surveillance of invasive mosquitoes in Europe</source>.
<publisher-loc>Stockholm</publisher-loc>:
<publisher-name>ECDC</publisher-name>; <year>2012</year> Available at:
<ext-link ext-link-type="uri" xlink:href="http://ecdc.europa.eu/en/publications/publications/ter-mosquito-surveillance-guidelines.pdf">http://ecdc.europa.eu/en/publications/publications/ter-mosquito-surveillance-guidelines.pdf</ext-link>.
Accessed 15 Jan 2016.</mixed-citation></ref><ref id="pntd.0005707.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Chanas</surname><given-names>AC</given-names></name>, <name><surname>Hubalek</surname><given-names>Z</given-names></name>, <name><surname>Johnson</surname><given-names>BK</given-names></name>, <name><surname>Simpson</surname><given-names>DI</given-names></name>. <article-title>A comparative study of O'nyong nyong virus with
Chikungunya virus and plaque variants</article-title>. <source>Arch
Virol</source>.
<year>1979</year>;<volume>59</volume>(<issue>3</issue>):<fpage>231</fpage>&#x02013;<lpage>8</lpage>.
.<?supplied-pmid 88212?><pub-id pub-id-type="pmid">88212</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Blackburn</surname><given-names>NK</given-names></name>, <name><surname>Besselaar</surname><given-names>TG</given-names></name>, <name><surname>Gibson</surname><given-names>G</given-names></name>. <article-title>Antigenic relationship between chikungunya virus strains
and o'nyong nyong virus using monoclonal antibodies</article-title>.
<source>Res Virol</source>.
<year>1995</year>;<volume>146</volume>(<issue>1</issue>):<fpage>69</fpage>&#x02013;<lpage>73</lpage>.
.<?supplied-pmid 7754238?><pub-id pub-id-type="pmid">7754238</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>EH</given-names></name>, <name><surname>Brewer</surname><given-names>TF</given-names></name>, <name><surname>Madoff</surname><given-names>LC</given-names></name>, <name><surname>Pollack</surname><given-names>MP</given-names></name>, <name><surname>Sonricker</surname><given-names>AL</given-names></name>, <name><surname>Keller</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Global capacity for emerging
infectious disease detection</article-title>. <source>Proc Natl Acad Sci
USA</source>.
<year>2010</year>;<volume>107</volume>(<issue>50</issue>):<fpage>21701</fpage>&#x02013;<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1006219107</pub-id>
.<?supplied-pmid 21115835?><pub-id pub-id-type="pmid">21115835</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref077"><label>77</label><mixed-citation publication-type="journal"><name><surname>Aghaie</surname><given-names>A</given-names></name>, <name><surname>Aaskov</surname><given-names>J</given-names></name>, <name><surname>Chinikar</surname><given-names>S</given-names></name>, <name><surname>Niedrig</surname><given-names>M</given-names></name>, <name><surname>Banazadeh</surname><given-names>S</given-names></name>, <name><surname>Mohammadpour</surname><given-names>HK</given-names></name>. <article-title>Frequency of dengue virus infection in blood donors in
Sistan and Baluchestan province in Iran</article-title>. <source>Transfus
Apher Sci</source>.
<year>2014</year>;<volume>50</volume>(<issue>1</issue>):<fpage>59</fpage>&#x02013;<lpage>62</lpage>.
<pub-id pub-id-type="doi">10.1016/j.transci.2013.07.034</pub-id>
.<?supplied-pmid 24332363?><pub-id pub-id-type="pmid">24332363</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref078"><label>78</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Ochieng</surname><given-names>C</given-names></name>, <name><surname>Wiersma</surname><given-names>S</given-names></name>, <name><surname>Stroher</surname><given-names>U</given-names></name>, <name><surname>Towner</surname><given-names>JS</given-names></name>, <name><surname>Whitmer</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Development of a TaqMan Array Card
for Acute-Febrile-Illness Outbreak Investigation and Surveillance of
Emerging Pathogens, Including Ebola Virus</article-title>. <source>J Clin
Microbiol</source>.
<year>2016</year>;<volume>54</volume>(<issue>1</issue>):<fpage>49</fpage>&#x02013;<lpage>58</lpage>.
<pub-id pub-id-type="doi">10.1128/JCM.02257-15</pub-id>
.<?supplied-pmid 26491176?><pub-id pub-id-type="pmid">26491176</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref079"><label>79</label><mixed-citation publication-type="journal"><name><surname>Pabbaraju</surname><given-names>K</given-names></name>, <name><surname>Wong</surname><given-names>S</given-names></name>, <name><surname>Gill</surname><given-names>K</given-names></name>, <name><surname>Fonseca</surname><given-names>K</given-names></name>, <name><surname>Tipples</surname><given-names>GA</given-names></name>, <name><surname>Tellier</surname><given-names>R</given-names></name>. <article-title>Simultaneous detection of Zika, Chikungunya and Dengue
viruses by a multiplex real-time RT-PCR assay</article-title>. <source>J
Clin Virol</source>.
<year>2016</year>;<volume>83</volume>:<fpage>66</fpage>&#x02013;<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jcv.2016.09.001</pub-id>
.<?supplied-pmid 27614319?><pub-id pub-id-type="pmid">27614319</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref080"><label>80</label><mixed-citation publication-type="journal"><name><surname>Waggoner</surname><given-names>JJ</given-names></name>, <name><surname>Gresh</surname><given-names>L</given-names></name>, <name><surname>Mohamed-Hadley</surname><given-names>A</given-names></name>, <name><surname>Ballesteros</surname><given-names>G</given-names></name>, <name><surname>Davila</surname><given-names>MJ</given-names></name>, <name><surname>Tellez</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Single-Reaction Multiplex Reverse
Transcription PCR for Detection of Zika, Chikungunya, and Dengue
Viruses</article-title>. <source>Emerg Infect Dis</source>.
<year>2016</year>;<volume>22</volume>(<issue>7</issue>):<fpage>1295</fpage>&#x02013;<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.3201/eid2207.160326</pub-id>
.<?supplied-pmid 27184629?><pub-id pub-id-type="pmid">27184629</pub-id></mixed-citation></ref><ref id="pntd.0005707.ref081"><label>81</label><mixed-citation publication-type="journal"><name><surname>Thiboutot</surname><given-names>MM</given-names></name>, <name><surname>Kannan</surname><given-names>S</given-names></name>, <name><surname>Kawalekar</surname><given-names>OU</given-names></name>, <name><surname>Shedlock</surname><given-names>DJ</given-names></name>, <name><surname>Khan</surname><given-names>AS</given-names></name>, <name><surname>Sarangan</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Chikungunya: a potentially emerging
epidemic?</article-title>
<source>PLoS Negl Trop Dis</source>.
<year>2010</year>;<volume>4</volume>(<issue>4</issue>):<fpage>e623</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0000623</pub-id>
. <?supplied-pmid 20436958?><pub-id pub-id-type="pmid">20436958</pub-id></mixed-citation></ref></ref-list></back></article>